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GENERAL INTRODUCTION 
Dietary cholesterol is of significant concern to a great 
number of people. Americans consuming a typical "Western" 
diet need to reduce their dietary intake of cholesterol to 
reduce their chances of suffering from coronary heart disease 
and stroke. Food industries are attempting to meet consumer 
demands for cholesterol-reduced products. One potential 
method to reduce cholesterol levels in foods is the use of 
enzymes to transform cholesterol into coprostanol, a sterol 
that is not absorbed by the human digestive system. It is 
possible that the use of cholesterol reductase might be 
relatively inexpensive and would be well-received by 
consumers. 
It was established in the 1930s that intestinal bacteria 
convert cholesterol to the saturated product coprostanol. 
Other early studies showed that whereas cholesterol was 
absorbed readily by the human digestive system, coprostanol 
was not absorbed. However, because cholesterol is absorbed 
in a region of the intestine that is proximal to the area 
that cholesterol-reducing bacteria (CRB) typically colonize, 
intestinal bacteria probably have little or no effect on 
serum cholesterol levels. 
Previous investigators were successful in isolating 
several strains of CRB. Most of these bacteria had 
characteristics that made common laboratory manipulations 
difficult. Requirements included the need for a lipid found 
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only in high concentrations in mammalian brain tissue and the 
need for complete anaerobiosis. These CRB also did not form 
colonies on solid plating media. 
The present study was undertaken to develop new methods 
for the cultivation of previously isolated CRB, and to 
isolate new strains of CRB with characteristics that might 
facilitate their application to reducing the cholesterol 
content of foods. 
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LITERATURE REVIEW 
Health Benefits of Reduced Serum Cholesterol Levels 
Although there is great variation from individual to 
individual, it has been proven that the intake of dietary 
cholesterol directly affects serum cholesterol levels. A 
predictive equation developed by Hegsted (1986) indicated 
that for a person consuming a 2500 kcal diet, an increase of 
100 mg per day of cholesterol would increase the serum 
cholesterol level by approximately 4 mg per dl. The most 
important health implication of elevated serum cholesterol is 
coronary heart disease (CHD). This disease is responsible 
for approximately one out of every three deaths in the United 
States (Levy, 1981). In 1958, the Western Electric Study was 
initiated. This study involved the detailed dietary and 
clinical histories of over 1900 middle-aged men (Shekelle et 
al., 1981). A 19-year follow-up study showed that a dietary 
reduction of 200 mg cholesterol per 1000 kcal resulted in a 
37% reduction in total mortality. The large body of evidence 
linking elevated serum cholesterol with CHD has been recently 
reviewed (National Research Council, Committee on Diet and 
Health, 1989). 
The American Heart Association and the National Heart, 
Lung, and Blood Institute have reviewed the epidemiologic, 
laboratory, and clinical studies linking cholesterol and CHD 
(Gotto, 1990). It was stated that there is a definite link 
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between elevated serum cholesterol levels and CHD, that diet 
modification can lower the risk of CHD, and that lowering 
serum cholesterol levels would be beneficial to everyone. 
Cholesterol and Colon Cancer 
Several studies have indicated a possible link between 
serum cholesterol levels or dietary cholesterol intake and 
colon cancer. Colon cancer is a major cause of neoplastic 
disease in populations consuming a Western diet (high in 
saturated fat and cholesterol, low in complex carbohydrates 
and fiber). The incidence of colon cancer is much reduced in 
populations consuming a non-Western diet (Hill and Aries, 
1971; Finegold et al., 1974). 
It has been suggested that the intestinal microflora 
acts upon dietary factors to form cancer-promoting compounds. 
Clostridia that dehydrogenate the steroid nucleus were 
isolated with increased frequency from fecal samples taken 
from subjects living in areas with a high incidence of colon 
cancer (Goddard et al., 1975). These Clostridia were also 
present more often in the feces of cancer patients than in 
the feces of control patients (Hill et al., 1975). 
Mastromarino et al. (1976) documented a significant increase 
in fecal microbial 7a-dehydroxy1ase and cholesterol 
dehydrogenase in the feces of colorectal cancer patients as 
compared to patients who did not have colorectal cancer. 
Studies of this type are complicated, however, by the 
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multiplicity of variables encountered when testing diseased 
subjects. 
One possible explanation for the link between 
high-cholesterol diets and colon cancer is that the diet 
affects the type and numbers of intestinal bacteria that are 
capable of forming cancer-promoting compounds. Drasar and 
Jenkins (1976) determined that various dietary 
supplementations that alter serum cholesterol levels had no 
effect on the fecal flora. Finegold et al. (1977) compared a 
group of people at low risk for developing colon cancer with 
a group of people at high risk. The low-risk group had 
increased fecal counts of aerobic bacteria and lowered counts 
of certain anaerobic bacteria in comparison to the high-risk 
group. There also appears to be no difference between the 
numbers of various taxonomical groups of intestinal bacteria 
of patients with large bowel cancer and healthy controls 
(Mastromarino et al., 1978). 
Bile acids are a group of metabolic end products that 
are affected by diet and the fecal microflora, and play a 
role in carcinogenesis. Cholesterol in the body is derived 
from two sources: exogenous cholesterol from the diet, and 
endogenous cholesterol that is synthesized in the liver and 
intestine. Cholesterol from both of these sources is 
metabolized in the liver, mainly to the primary bile acids, 
cholic acid and chenodeoxycholic acid. These bile acids are 
conjugated with taurine and glycine; the conjugates are 
secreted into the intestine. The microflora in the large 
f 
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bowel is capable of deconjugating these bile acids. 
Approximately 80% of the free bile acids are then converted 
to deoxycholic acid and lithocholic acid by bacteria that 
express the enzyme 7a-dehydroxylase. These steroids are 
referred to as secondary bile acids. 
Several lines of evidence have implicated secondary bile 
acids as causative agents in colon cancer. Bile acids have 
structural similarities with the polycyclic aromatic 
hydrocarbons, compounds that are known carcinogens. 
Epidemiological studies have linked the Western diet, 
increased concentrations of secondary bile acids, and colon 
cancer. Certain sterols and bile acids have shown 
tumor-promoting activity in experimental carcinogenesis 
studies. Secondary bile acids may inhibit the host's ability 
to detoxify exogenous carcinogens. Finally, secondary bile 
acids can exhibit mutagenicity, transforming activity, and 
DNA-strand breakage (reviewed by Nair, 1988). 
On the average, greater than 70% of fecal cholesterol is 
converted to coprostanol in the large intestine of healthy 
adult humans (Wilkins and Hackman, 1974). It has been 
suggested by several investigators that the microbial 
conversion of cholesterol to its reduced products may be 
associated with the development of colon cancer. These 
speculations have been based entirely upon epidemiological 
studies, and to date no direct evidence implicating the 
reduced products of cholesterol with colon cancer has been 
presented (Macdonald et al., 1983; Goldin, 1986). 
Absorption of Sterols by the Human Digestive System 
The transfer of sterols from the lumen of the 
gastrointestinal system to the circulatory system or lymph 
involves several steps. The process includes the transfer of 
the sterol into the mucosal cells, metabolic processing in 
the mucosa, and transfer into the lymph. Sterols that are 
absorbed can originate either from dietary sources or from 
endogenous sources that include bile, saliva, gastric 
secretions, and cells sloughed from the intestinal mucosa. 
Approximately 400 to 1000 mg of cholesterol, 100 to 500 mg of 
bile acids, and less than 2 mg of steroid hormones pass 
through the colon of the average human each day (Macdonald et 
al., 1983). The amount of cholesterol that is absorbed by 
the intestine varies greatly between individuals and is 
dependent upon other dietary components such as the amounts 
and degree of saturation of fats. In general, approximately 
20 to 50% of total cholesterol is absorbed (Treadwell and 
Vahouny, 1977). Cholesterol and related sterols are absorbed 
primarily in the proximal region of the jejunum (Borgstrom, 
1960). 
When a sterol is absorbed, it is esterified in the 
intestinal mucosal cells. The ability to be esterified seems 
to be one of the major determining factors that distinguishes 
sterols that enter the lymph from those that do not. Sterols 
that are esterified must have a free hydroxyl group at C-3 of 
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ring A in the 13 position, and the A and B rings must be 
oriented trans:trans. A double bond at the C-5 position is 
not required, and a double bond or a hydroxyl group at C-7 of 
ring B or an alteration of the side chain inhibits 
esterification. Although most sterols are not absorbed if 
they are not efficiently esterified, epicholesterol is not 
esterified, but is absorbed, and dihydrocholesterol is 
esterified, but is absorbed only half as efficiently as 
cholesterol. Coprostanol is very poorly esterified (reviewed 
by Treadwell and Vahouny, 1977). 
Some of the earliest studies on the absorption of 
sterols were carried out by Schoenheimer (1931). Large 
amounts of various sterols were fed to animals, and the 
thoracic duct lymph was analyzed. Sterols that were absorbed 
by the intestine would appear in the lymph. From these 
studies it was concluded that plant sterols and coprostanol 
were completely nonabsorbable. 
Much of the information available on the absorbability 
of sterols resulted from balance studies. In this type of 
study, the amount of a sterol that is ingested by an animal 
is compared with the amount that is excreted in the feces, 
after correcting for sterol synthesis by the animal. When 
sitosterol, ergostanol, cholestanol, and coprostanol were fed 
to mice, there was no change in the sterol balance. Sterol 
synthesis in these animals remained the same as when they 
were fed a sterol-free diet. It was concluded that 
coprostanol was not absorbed by the intestinal system of the 
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mouse (Breusch, 1938). 
The nonabsorbability of coprostanol by the intestinal 
systems of animals was questioned by Setty and Ivy (1960). 
When 28 mg per day of coprostanol was added to the diet of 
rats, an average of 48% of the sterol was absorbed. They 
also determined that 65% of cholesterol and 22% of 
cholestanol were absorbed. The methods used in these studies 
may account for the differences in coprostanol absorption 
reported by Setty and Ivy (1960) and those reported by other 
workers. Coprostanol was measured by the analysis of the 
difference between the total sterol, determined by digitonin 
precipitation of the mixture, and the amount of cholesterol, 
calculated from a color reaction with the Liebermann-Burchard 
reagent. It was subsequently found that this procedure was 
not accurate for coprostanol determination (Wells and Mores, 
1961). 
A more sensitive method for determining sterol 
absorption is through the administration of radiolabeled 
sterols. Rosenfeld and coworkers (1963) fed coprostanol-C^^ 
and cholestanol-C^^ to two human subjects. At the peak of 
plasma radioactivity, one subject had 3.6% of the 
administered coprostanol-C^^ in the plasma, and the second 
subject had 3.5%. The amount of ingested cholestanol-C^^ in 
the plasma of one subject was 4.7%. The second subject was 
not tested. The cholestanol that appeared in the plasma had 
been esterified, whereas none of the coprostanol was 
esterified. 
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Bhattacharyya (1986) fed fasted rats coprostanol and 
cholestanol. After 4 hours, the rats were sacrificed and the 
small intestine was dissected. The total intestinal tissue 
content of coprostanol was only 3.8% of the total dose fed, 
while the content of cholestanol was 14.6% of the dose fed. 
The amount of cholestanol that was esterified was 5 to 30 
times higher than the amount of esterified coprostanol in all 
sections of the intestine tested. 
In another experiment by the same investigator, the 
small intestine was removed from fasted rats, washed, 
everted, and formed into sacs. These sacs were then 
incubated in buffer with and without coprostanol or 
cholestanol. The percent uptake of cholestanol was 
significantly higher than that of coprostanol in all of the 
segments of the small intestine. The author stated that 
coprostanol was not absorbed because its uptake and 
esterification by the intestinal mucosal cells was extremely 
limited, while the uptake and esterification of cholestanol 
was not limited. 
Several possible reasons for the difference in uptake 
were tested. It was thought that there may have been a 
difference in the solubility of the two sterols in mixed 
micelles, thereby limiting the availability of coprostanol to 
the mucosal cells. However, no difference was observed in 
the concentrations of the two sterols in the mixed micellar 
layer isolated from the intestinal contents of the sterol-fed 
animals. Another postulate was that the sterols formed 
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different structures in mixed micelles that altered their 
ability to diffuse out of the micelles. The rate of 
diffusion of coprostanol out of mixed micelles was observed 
to be significantly slower than the diffusion of cholestanol. 
This may be the reason for the lower uptake of coprostanol by 
intestinal mucosal cells compared to the uptake of 
cholestanol. Another reason may be the structural difference 
between the two sterols. The A/B ring structure of 
coprostanol is cis, which causes the C-3 hydroxy group to 
assume an equatorial position. Cholestanol and cholesterol 
each have trans A/B ring junctions, with the 3-hydroxy group 
in the axial position. 
Cholesterol-reducing Bacteria 
Schoenheimer stated in 1931, "Since koprosterol was not 
found in the tissues but always in larger amounts in the 
feces, we must still assume that it is a product of the 
bacterial action in the intestines even though we have not 
been able to reproduce the same in vitro. We must consider 
that up to the present it has not been possible to cultivate 
all of the intestinal bacteria and it is very probable that 
any one of the difficultly cultivatable anaerobes may be able 
to bring about this change. It is hoped that the near future 
may throw light on this question." It was not until 42 years 
later that a pure culture of a cholesterol-reducing bacterium 
was isolated (Eyssen et al., 1973). 
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In 1934, Dam observed that cholesterol was readily 
reduced to coprostanol (also called coprosterol and 
koprosterol) by mixed fecal cultures from humans or rats. If 
the feces were heated to 100 °C for 20 min, no hydrogénation 
of cholesterol occurred. Rosenheim and Webster (1943) 
determined that the administration of the bacteriostatic 
agent succinylsulphathiazole to rats inhibited coprostanol 
formation in vivo. 
Further attempts to isolate a cholesterol-reducing 
bacterium were reported by Snog-Kjaer et al. (1956). A 
medium was formulated that included 5% (w/v) desiccated hog 
or ox brain. Brain was used because it provided an easy way 
to produce a colloidal suspension of cholesterol. This 
medium was made partially anaerobic by the addition of the 
reducing agent cysteine hydrochloride and incubation in 
vacuo. Mixed cultures of fecal bacteria saturated 80 to 93% 
of the sterols when incubated in the brain medium for 8 d at 
37°C. However, pure cultures of Clostridium welchii, 
Clostridium sporogenes. Bacterium bifidum, various 
streptococci and micrococci, Escherichia coil, and Aerobacter 
aerogenes failed to hydrogenate the cholesterol substrate. 
The investigators also noted that copper sulfate was not 
inhibitory to the anaerobic cholesterol-reducing bacteria, 
and that the reducing activity of mixed cultures of fecal 
anaerobes was maintained after storage at 15°C for 6 months. 
Although the bacterium responsible for cholesterol 
conversion into coprostanol had not yet been isolated. 
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several studies were carried out to determine the effects on 
coprostanol formation of adding different compounds to the 
diet. Penicillin, sulfa suxidine, Tween 80, and sodium 
taurocholate depressed the excretion of coprostanol in rats. 
Aureomycin, streptomycin, and Chloromycetin had no effect 
(Wells, 1957). When rats were fed a 40% lactose diet, total 
liver cholesterol was elevated compared to controls, and 
markedly less coprostanol was excreted in the feces (Wells 
and Cooper, 1958). This effect was thought to have been 
caused by a decrease in the intestinal pH from an average 
value of 7.65 in control rats to 5.80 in lactose-fed rats. 
Interestingly, when the lactose diet was supplemented with 2% 
calcium chloride, total liver cholesterol was decreased, and 
coprostanol was returned to normal levels in fecal samples. 
The authors postulated that calcium formed insoluble 
complexes with phospholipids or fatty acids, and that these 
complexes were involved in the cholesterol-absorption 
inhibition. 
Crowther et al. (1973) investigated the effects upon the 
fecal flora of feeding a liquid diet to human volunteers. 
These researchers claimed that several pure cultures of 
bacteria converted cholesterol to coprostanol when the 
bacteria were grown in the brain medium of Snog-Kjaer et al. 
(1956). Of 20 strains of Clostridium spp. tested, 9 were 
positive, and converted 15 to 20% of the cholesterol to 
coprostanol. Eighteen strains of Bacteroides spp. and 12 
strains of Bifidobacterium spp. were tested, with 12 and 9 
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strains positive, respectively. Some Bacteroides strains 
converted more than 50% of the cholesterol substrate after 
7 d of incubation. 
Sadzikowski and coworkers (1977) tried to repeat the 
experiments conducted by Crowther's group (1973) because the 
original strains of cholesterol-reducing bacteria had been 
lost. Using the same methods and media, Sadzikowski and 
coworkers (1977) were not able to isolate any 
cholesterol-reducing bacteria. The inability of subsequent 
investigators to demonstrate cholesterol reduction by pure 
cultures of similar strains of bacteria remains to be 
explained. 
The first isolation of a pure culture of a 
cholesterol-reducing bacterium was most likely accomplished 
by Eyssen et al. (1973). A basal medium was formulated that 
contained freeze-dried beef brain powder as the cholesterol 
source. This medium was prereduced, and growth was carried 
out under a nitrogen atmosphere. Rat cecal contents were 
inoculated into this medium, and small amounts of coprostanol 
were observed after the medium was incubated. The sterols 
were extracted, and the samples were spotted on thin layer 
chromatography plates. Greater concentrations of coprostanol 
were observed after several successive transfers of the 
culture into fresh medium, and by the 15th transfer, 90% of 
the cholesterol was hydrogenated within 72 h. When those 
cultures were streaked on agar-containing plates of the same 
medium, none of the colony-forming bacteria could convert 
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cholesterol to coprostanol in liquid culture media. However, 
a mixed culture that contained only a Clostridium perfringens 
and a small Gram-positive bacterium did convert cholesterol 
to coprostanol. When this culture was passed through a 0.8 
/nm syringe filter, a pure culture of the small bacterium was 
obtained that reduced cholesterol in the brain-containing 
medium. 
The cholesterol-reducing bacterium was small, anaerobic, 
and Gram positive in young cultures, but became Gram negative 
after 3 d of incubation. Many diploforms were observed in 
young cultures. The organism did not grow in many commonly 
used media, even after supplementation with serum or yeast 
extract. However, when 1 to 2 mg/ml cholesterol suspended in 
lecithin was added, these media supported growth for a 
limited number of transfers. After approximately 10 
transfers, these media no longer supported growth of this 
bacterium. Long-term propagation could only be carried out 
on media containing brain powder. It was concluded that the 
organism had an obligate requirement for a delta-5 sterol. 
The cholesterol-reducing bacterium grew optimally at 37° 
to 40°C, and did not produce spores. Tests for the 
production of indole, acetyl-methyl-carbinol, hydrogen 
sulfide or catalase were negative, and nitrate was not 
reduced to nitrite. The organism was not motile, and 
produced small amounts of acid and gas from glucose, lactose, 
galactose, and melibiose. No acid or gas was observed after 
growth in media containing maltose, fructose, raffinose. 
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mannose, trehalose, melezitose, xylose, or rhamnose. The 
bacterium was classified in the genus Eubacterium and was 
registered by the American Type Culture Collection as 
Eubacterium ATCC 21408. 
In addition to cholesterol, Eubacterium 21408 also 
reduced 4-cholesten-3-one to coprostanol. Sitosterol, 
campesterol, stigmosterol, 5-androsten-3B-ol-17-one, and 
5-pregnen-3,20B-diol were converted to their corresponding 
5-hydrogenated derivatives. There was no conversion of 
cholesteryl acetate or cholesteryl chloride. 
Several studies were initiated to determine the role of 
cholesterol-reducing bacteria in the intestine. When the 
feces of conventional rats or of gnotobiotic rats inoculated 
with a cholesterol-reducing bacterium were tested, 
cholesterol was extensively reduced to coprostanol. However, 
in cecectomized rats, this activity was lost within 2 d of 
the operation (Eyssen et al., 1972). Eubacterium 21408 was 
eliminated from the intestine of cecectomized rats. The 
change in pH or Eh of the intestinal contents was found not 
to be the reason for the loss of the bacterium. It was 
postulated that the cecum was necessary to slow the 
intestinal transit time enough to allow the growth of the 
slowly-developing eubacterium. 
Crowther et al. (1973) determined that in humans the 
intestinal transit time was not crucial in maintaining 
cholesterol-reducing bacteria. When healthy volunteers were 
fed a fat-free liquid diet, the percentage of neutral 
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steroids excreted in the feces as coprostanol decreased. 
This decrease in the excretion of coprostanol may have been 
caused by an alteration of the bacterial species present in 
the gut, or because the enzyme responsible for cholesterol 
reduction was synthesized at a lower level due to a lack of 
substrate. Fecal transit time in these volunteers was 
actually longer than in controls (Crowther et al., 1973). 
The percentage of cholesterol converted to coprostanol 
in healthy volunteers on a North American diet was 
categorized into two distinct patterns: low conversion and 
high conversion (Wilkins and Hackman, 1974). In a group of 
31 volunteers, fecal samples from 8 people contained less 
than 30% of coprostanol as total animal sterols, while the 
fecal samples from the other 23 volunteers contained greater 
than 60% coprostanol. Because all the volunteers were 
consuming similar diets and the patterns were stable with 
time, it was thought that the differences must be at the 
level of the microbial ecology of the colon. Factors 
affecting cholesterol conversion may have been the 
composition of the intestinal microflora, the physical state 
of the cholesterol molecule in the intestine, or the 
intestinal transit time (Wilkins and Hackman, 1974). 
The effect of various sugars on the conversion of 
radiolabeled cholesterol to coprostanol in human fecal 
homogenates was tested (Subbiah et al., 1974). When lactose, 
galactose, fructose, sucrose, or glucose were added to the 
homogenates, the percent of cholesterol converted to 
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coprostanol decreased significantly. It was noted that this 
decreased conversion may have been caused by a shift in pH or 
by a catabolite repression effect. The exact mechanism was 
not elucidated. 
Working with pure cultures of Eubacterium 21408, Eyssen 
et al. (1974) observed that lactose did not inhibit growth of 
the bacterium. However, when the bacterium was cocultured 
with a Clostridium sp., an Escherichia coli, or a 
Streptococcus faecalis in the presence of lactose, it was 
inhibited in its growth. The decrease in pH caused by the 
fermentation of lactose by the other bacteria was thought to 
have been responsible for the inhibition of Eubacterium 
21408. 
Sadzikowski and coworkers (1977) were the first 
researchers to isolate a cholesterol-reducing bacterium from 
human feces. A human fecal sample was serially diluted and 
inoculated into a pork brain-containing prereduced medium. 
The highest dilution that formed coprostanol upon incubation 
was again serially diluted and inoculated into the medium. 
After several consecutive serial dilutions, the mixed culture 
was treated with clindamycin, erythromycin, penicillin G, and 
phenethyl alcohol. The only remaining bacterium visible upon 
microscopic examination of the resulting 
coprostanol-producing culture was a Gram-positive 
diplobacillus. 
The cholesterol-reducing bacterium isolated from human 
feces by Sadzikowski et al. (1977) was very similar to the 
19 
bacterium isolated by Eyssen's group (1973). The isolate did 
not form colonies on a variety of aerobic or anaerobic agar 
plating media, and did not grow in any of the conventional 
broths that were tested. The human isolate also had an 
obligate requirement for cholesterol. 
In an attempt to explain the differences in coprostanol 
excretion between high and low converters observed by Wilkins 
and Hackman (1974), the cholesterol-reducing bacterium of 
human origin and Eubacterium 21408 were incubated with 
several strains of bacteria to check for inhibition. An 
organism tentatively identified as Fusobacterium russii 
caused a 40% inhibition of coprostanol formation by 
Eubacterium 21408. However, Sadzikowski's isolate was only 
slightly inhibited (Sadzikowski et al., 1977). It was 
concluded that one reason that some people convert a greater 
percent of cholesterol to coprostanol is that their 
cholesterol-converting flora respond differently to 
antagonistic bacteria that are present in the intestine. 
Using techniques similar to those used by previous 
investigators (Eyssen et al., 1973; Sadzikowski et al., 
1977), a cholesterol-reducing bacterium was isolated from 
baboon feces (Mott and Brinkley, 1979). This isolate was 
designated Eubacterium 403, and was nearly identical to the 
previous isolates. All of the cholesterol-reducing bacteria 
would grow for only a limited number of transfers in 
brain-free media supplemented with cholesterol in lecithin. 
For long-term maintenance, the addition of homogenized brain 
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or lipid extracts of brain was required. By separating an 
organic solvent extract of brain into its components, it was 
determined that the bacteria required a plasmalogen, 
plasmenylethanolamine (PLE) (Mott and Brinkley, 1979). PLE 
is similar to phosphatidylethanolamine, except that it 
contains an alkenyl ether linkage at C-1. When pure PLE was 
added to a medium that contained cholesterol dispersed with 
lecithin, the eubacteria grew, formed fibers, and solidified 
the medium. The cultures also catabolized PLE as it was 
observed that the PLE disappeared with cell growth. It was 
also determined that coprostanol formation was directly 
related to the PLE concentration. 
Using a simplified medium containing PLE, it was 
possible to study the metabolic characteristics of 
cholesterol-reducing bacteria. Mott et al. (1980) studied in 
detail the biochemical characteristics of Eubacterium 21408 
and 403. These strains were negative for nitrate reduction, 
indole production, and gelatin and starch hydrolyses. There 
was no fermentation of the 22 carbohydrates tested. Both 
strains were positive for esculin hydrolysis and did not 
possess an arginine dihydrolase pathway. In addition to PLE, 
5 other alkenyl ether lipids supported the growth of the 
eubacteria in a cholesterol-lecithin medium. Allocholesterol 
and 4-cholesten-3-one were reduced to coprostanol. When the 
medium contained 2 mg per ml of 4-cholesten-3-one, 
coprostanone was the major product after incubation. But if 
the level of this sterol was reduced to 0.2 mg per ml, the 
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major product was coprostanol. The authors concluded that 
the cholesterol-reducing bacteria resembled Eubacterium 
lentum, but because they lacked the arginine dihydrolase 
pathway and had a unique requirement for certain sterols and 
alkenyl ether lipids, they could not be classified in any 
existing species within the genus Eubacterium. 
A major problem in performing various laboratory 
procedures with the cholesterol-reducing bacteria was the 
inability to grow the bacteria on a solid medium. Brinkley 
et al. (1980) developed a cholesterol-brain agar medium (CBA) 
that sustained the growth and colony formation of these 
bacteria when used in an anaerobic chamber. The medium 
contained 5% cholesterol dispersed with 0.1% lecithin and 3% 
freeze-dried brain. This very high concentration of 
cholesterol was thought to be necessary to overcome the 
limited diffusion of water-insoluble sterols through the agar 
matrix. Casamino Acids and yeast extract were also necessary 
for growth. Trypan blue dye was added to aid in the 
visualization of the colonies. The colonies were very small, 
had a fibrous appearance, and did not decolorize the trypan 
blue as many other anaerobes did. 
The cholesterol-brain agar medium was used to isolate 
several new strains of cholesterol-reducing bacteria 
(Brinkley et al., 1982). Feces or intestinal contents were 
obtained from baboons, diluted, and plated on CBA. After 3 
to 5 d of incubation, colonies that had the characteristic 
appearance of previously isolated cholesterol-reducing 
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bacteria were picked and inoculated into brain-containing 
media. Using this method, 9 new strains of 
cholesterol-reducing bacteria were isolated. All of these 
new strains formed tiny colonies on brain heart infusion agar 
supplemented with sodium pyruvate and yeast extract. This 
finding was significant because it indicated that not all 
cholesterol-reducing bacteria have an obligate growth 
requirement for cholesterol and PLE. The strains reduced 
cholesterol to coprostanol when grown in cholesterol-lecithin 
medium containing PLE. Two of the strains could reduce 
cholesterol in the absence of PLE, while the other 7 strains 
required PLE to reduce cholesterol. These two strains also 
produced succinate. All of the strains produced small 
amounts of acetate. Unlike previously isolated strains of 
cholesterol-reducing bacteria, several of the new isolates 
produced acid from various carbohydrates. Every stain of 
cholesterol-reducing bacterium tested metabolized pyruvate, 
and produced acetoin. In the presence of pyruvate, the 
strains produced COg concentrations of from 9 to 20% of the 
headspace gas. The isolates were negative for starch and 
gelatin hydrolysis, did not reduce nitrate, and did not 
produce indole, urease, or hydrogen. 
Mechanism of Cholesterol Reduction 
Early studies of the conversion of cholesterol to 
coprostanol were conducted by using fecal homogenates that 
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contained a mixture of bacterial cultures. In an attempt to 
elucidate the mechanism of this reaction, various 
radiolabeled cholesterol substrates were incubated with 
feces, and the coprostanol product was then analyzed. A 
dual-labeled cholesterol compound (cholesterol-3d,4-^^C) was 
fed to human volunteers. When coprostanol excreted in the 
feces was assayed, the ratio of deuterium to remained the 
same. This indicated that, during the conversion of 
cholesterol to coprostanol, the hydrogen group at C-3 
remained intact. Incubation of the labeled cholesterol with 
fecal material confirmed the results. However, when the 
group at C-3 was oxidized to the corresponding ketone, the 
coprostanone still contained an appreciable level of 
deuterium. It was concluded that the conversion of 
cholesterol to coprostanol must be a more complicated 
reaction than the simple reduction of the 5-6 double bond 
(Rosenfeld et al., 1954). Further experimentation 
established that the deuterium that had been removed from the 
C-3 position was moved to C-5 and C-6, and possibly 
exclusively to C-6 (Rosenfeld et al., 1956). 
Rosenfeld and Gallagher (1964) determined that when 
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cholesterol-3- H was transformed to coprostanol- H by human 
fecal suspensions, most of the tritium was retained at C-3, 
suggesting that the hydroxyl group at C-3 was not oxidized to 
a ketone during the formation of coprostanol. However, in 
some experiments, a significant amount of the tritium was 
lost or transferred to new positions of the coprostanol 
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molecule. The authors concluded that the reduction of 
cholesterol to coprostanol could be achieved by at least two 
different microorganisms by at least two chemical pathways. 
One pathway involved the intermediate formation of 
coprostanone, while another did not. 
Bjorkhem and Gustafsson (1971) anaerobically incubated 
[4B-^H,4-^^C]- and [3a-^H,4-^^C]cholesterol with cecal 
contents from rats. When the 3a-^H compound was converted 
into coprostanol, 50% of the tritium was lost. When 
[4-^4c]cholesterol with no tritium label was incubated in the 
presence of [3a-^H]6-sitosterol, the ^^C-labeled coprostanol 
contained significant amounts of tritium in the C-3a 
position. This indicated that some of the tritium that 
remained in the C-3 position may have been introduced in a 
reductive step following an initial oxidation step. These 
experiments provided evidence that an intermediate ketone was 
involved in cholesterol reduction. When the 46- H compound 
was incubated with cecal contents, 40% of the tritium was 
lost. Of the tritium that remained, most had been 
transferred to the C-6 position. This indicated that the 
double bond at the C-5 position of cholesterol was isomer!zed 
to the 4 position during coprostanol formation. 
The only attempt to purify the enyzme(s) responsible for 
the biohydrogenation of cholesterol to form coprostanol was 
carried out by Bjorkhem and coworkers (1973). They obtained 
a crude enzyme preparation by freeze-pressing the cecal 
contents of rats. After centrifugation at 100000 X g, 
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3-oxo-delta-4-steroid 5J3-reductase activity was found mainly 
in the supernatant. About half this activity could be 
precipitated between 25 and 50% saturation with ammonium 
sulfate. Approximately 70% of the activity was lost when the 
extract was stored at 4°C for 48 h. Attempts to further 
purify the enzyme by Sephadex chromatography, DEAE-cellulose 
chromatography, and hydroxyapatite chromatography were not 
successful because of the rapid loss in enzyme activity. 
Freeze-pressing was the only method of cell breakage that did 
not destroy enzyme activity. The other methods that were 
tried included sonification, treatments with detergents, 
treatment with lysozyme-EDTA, and sand-milling. 
Although the conversion of cholesterol to coprostanol 
was studied, the only activity found in cell-free extracts of 
rat cecal contents was the reduction of 4-cholesten-3-one, 
progesterone, testosterone, and 7a-hydroxy-4-cholesten-3-one 
to the corresponding 3-keto-56-steroids (Bjorkhem et al., 
1973). There was no activity with cholesterol, pregnenolone, 
or dehydroepiandrosterone as substrates. The 
delta-4-reductase used NADH as a cofactor, but not NADPH. 
The mechanism of reduction involved the transfer of hydrogen 
from the 4B-position of NADH to the 5J3-position of the 
steroid. There was a sharp pH optimum at 6.5. 
Experiments similar to those carried out by Bjorkhem and 
Gustafsson (1971) on rat cecal contents were carried out by 
Parmentier and Eyssen (1974), except Eubacterium ATCC 21408 
was used instead of a mixed culture. They observed a 65% 
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loss of tritium when [3a-^H,4-^^C]cholesterol was converted 
into coprostanol. However, when preformed 
[3a-^H,4-^*C]coprostanol was incubated with the bacterium, 
40% of the tritium was lost. The authors concluded that 
reversible oxidation-reduction reactions were being carried 
out at the 3-hydroxyl group, and that this information could 
not be used to determine the mechanism of cholesterol 
reduction. When [4B-^H,4-^^C]cholesterol was incubated with 
Eubacterium 21408, 81% of the tritium was retained, but 
greater than 90% of the retained label was located at the C-6 
position of coprostanol. This indicated that the reduction 
of cholesterol by this bacterium involved the intramolecular 
shift of tritium from C-4 to C-6, suggesting that the 
intermediate formation of 4-cholesten-3-one was the major 
pathway for the conversion of cholesterol to coprostanol by 
Eubacterium ATCC 21408. 
Other Related Microbial Steroid Reactions 
The study of related microbial steroid reactions is of 
great value when investigating cholesterol reduction to 
coprostanol, because there may be many similarities. 
Anaerobic bacteria in the intestine act on cholesterol, bile 
acids, and steroid hormones. Some reactions that may have 
similar characteristics to the conversion of cholesterol to 
coprostanol will be considered. 
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It was demonstrated that Clostridium paraputrificum 
could transform 4-androsten-3,17-dione to 
3a-hydroxy-5B-androstan-17-one with 56-androstan-3,17-dione 
as an intermediate (Glass et al., 1979). The initial 
reaction was the complete reduction of the double bond at 
C-4, which was carried out by early log phase cells. The 
next reaction was the reduction of the keto group at C-3, and 
occurred most rapidly as the culture entered stationary 
phase. The product of this second reaction did not appear 
until 2 h after the formation of the intermediate. When 
crude cell extracts were assayed, the reaction proceeded as 
it did with growing whole cells, and no exogenous cofactors 
were required. No special precautions were taken to maintain 
anaerobic conditions during the harvesting and breakage of 
the cells. 
To test for cofactor requirements, crude cell extracts 
of C. paraputrificum were treated with a Sephadex G-25 column 
to remove low molecular weight compounds (Glass et al., 
1979). It was observed that the addition of NADH with FAD or 
FMN or the addition of NADPH with FAD greatly increased the 
activity of the enzyme system. These data suggested the 
presence of an electron transport system. 
Quantitatively, the most important steroid reaction 
carried out by intestinal anaerobic bacteria is the 
7a-dehydroxylation of cholic acid and chenodeoxycholic acid 
to form the secondary bile acids deoxycholic and lithocholic 
acids. This reaction has a significant impact on the 
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physiology of the host, and has been studied in great depth. 
Clostridium leptum was assayed in an anaerobic washed whole 
cell system radiochromatographically by Stellwag and Hylemon 
(1979). A pH optimum of 6.5 to 7.0 was determined for 
7a-dehydroxylase. There was a 10-fold increase in 
the 7a-dehydroxylation of cholic acid during the transition 
from logarithmic to stationary growth phase, and the increase 
occurred both with and without cholic acid in the growth 
medium. The reaction showed a high degree of substrate 
specificity and was very sensitive to inhibition by molecular 
oxygen. The authors noted that the reaction seemed to occur 
in or on the cytoplasmic membrane and speculated that 
7a-dehydroxylation was coupled to an energy generating system 
in Clostridium leptum. 
Eubacterium sp. strain VPI 12708 was determined to have 
inducible 7a-hydroxylase activity (White et al., 1980). The 
activity was demonstrated both in washed whole cells and in 
cell-free extracts. The induction of the enzyme was highly 
specific and required a free carboxy group and an unhindered 
7a-hydroxy group on the B ring of the bile acid. It was also 
determined that cholic acid induced NADH;flavin 
oxidoreductase activity. It appeared that the NADH:flavin 
oxidoreductase may have been supplying reduced flavin that 
was required by the 7a-dehydroxylase. The cholic 
acid-inducible NADH:flavin oxidoreductase was purified and 
further characterized (Lipsky and Hylemon, 1980). The enzyme 
had an absolute specificity for NADH as the electron donor 
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but could use a variety of electron acceptors, including 
2,6-dichlorophenolindophenol, KgFefCNjg, methylene blue, 
menadione, riboflavin, FMN, and molecular oxygen. 
As is the case with most cholesterol reductases studied, 
7a-dehydroxylase is believed to act by a multiple-step 
pathway. The initial step of 7a-dehydroxylation of bile 
acids was thought to be the diaxial transelimination of water 
resulting in the elimination of the 7a-hydroxy group and the 
6B-hydrogen. The double bond at C-6 was then believed to be 
reduced at the 6a and 7B position (Samuelsson, 1960). 
Suprisingly, White and coworkers (1981) determined that NAD*^ 
was required for enzyme activity in anaerobic dialyzed 
cell-free extracts, rather than a reduced cofactor. They 
also found that the delta-6 intermediate did not accumulate 
and that the 7a-dehydroxylase activity and the delta-6 
reduction activity eluted from gel filtration columns as a 
single peak. It was also determined that Eubacterium 12708 
could 76-dehydroxylate ursodeoxycholic acid to lithocholic 
acid (White et al., 1982). The investigators suggested that 
a single enzyme or enzyme complex may have catalyzed the 
multiple-step reaction. Further study by the same group 
(White et al., 1983) suggested that 7-dehydroxylase was 
regulated by the NAD^-NADH ratio in the bacterial cell. 
7a-Dehydroxylation of bile acids was also demonstrated 
in resting cells of an unidentified Gram-positive, 
nonsporing, anaerobic bacterium by Masuda and Oda (1983). 
With this bacterium, when the glucose concentration in the 
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growth medium was increased from 0.3 to 1.0%, enzyme activity 
was completely lost, even though there was an enhancement of 
cell growth. It was suggested that a decrease in pH may have 
been responsible, or that glucose may have repressed 
7a-dehydroxylase production. 
Masuda et al. (1984) studied 7a-dehydroxylation by 
resting cells of a Eubacterium lentum-li'ke bacterium (strain 
c-25). The organism could grow only under strict anaerobic 
conditions. However, when a cell suspension was exposed to 
atmospheric oxygen for 1 hour, less than 10% of the 
7a-dehydroxylase activity was lost. When the cells were 
ruptured by sonic oscillation, enzyme activity was completely 
lost. The pH optimum for activity against cholic acid was 
7.3, while the optimum against chenodeoxycholic acid was 7.7, 
suggesting the presence of 2 distinct enzymes. 
Cell extracts of Eubacterium 12708 produced a novel 
highly polar bile acid metabolite when grown in the presence 
of primary bile acids (Coleman et al., 1987a). It was 
determined that this compound contained a nucleotide with a 
pyrophosphate group covalently linked to the bile acid at the 
C-24 position. It was thought that this metabolite was an 
intermediate in the 7-dehydroxylase reaction. This new 
evidence led to a modification in the proposed pathway of 
7-dehydroxylation. It was proposed that the mechanism 
involved an initial two-step oxidation of a primary bile acid 
nucleotide to produce a 3-oxo-delta-4,6-steroid nucleotide. 
There is then a three-step reduction of the intermediate, and 
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the bound nucleotide is relinked to 7-dehydroxylase, 
releasing the secondary bile acid. 
Because the 7-dehydroxylase of Eubacterium 12408 was 
inducible, it was possible to determine that four new 
polypeptides were synthesized after exposure to cholic acid 
(White et al., 1981; Paone and Hylemon, 1984). The greatest 
activity corresponded with a polypeptide that had a molecular 
weight of 27000 (PP-27). PP-27 was purified, the 
amino-terminal end of the molecule was sequenced, and the 
corresponding mixed oligonucleotide probe was sythesized. 
This probe hybridized with a 2.2-kilobase EcoRI fragment. 
Size fractionation of a total digest of genomic DNA enriched 
for the 2.2-kilobase fragment. This enriched fragment was 
ligated into the bacterial plasmid pUC8 and used to transform 
Escherichia coli HBIOI. The use of the probe in a colony 
hybridization procedure allowed the detection of the 
7-dehydroxylase gene in the transformants. The entire gene 
was cloned on a 1150-base-pair ÎPagI fragment. Western blot 
analysis indicated that PP-27 was expressed in E, coli. This 
was the first reported cloning of a bile acid metabolism gene 
and the first gene cloned from a Eubacterium sp. (Coleman et 
al., 1987b). PP-27 was shown to be associated with 
7-dehydroxylation, although purified PP-27 did not exhibit 
enzymatic activity. It was thought that PP-27 was involved 
in at least one of the oxidation-reduction reactions of 
7-dehydroxylation (Coleman et al., 1988). 
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To further elucidate the mechanism of 7-dehydroxylation, 
(3B-^H)- and (5-^H)-labeled cholic acid were used as 
substrates for whole cells and extracts of Eubacterium 12708 
(Bjorkhem et al., 1989). The majority of the label was lost 
during 7-dehydroxylation, suggesting the formation of a 
3-oxo-delta-4 intermediate. It was thought that some was 
retained because it was transferred from the labeled bile 
acid to a cofactor in an oxidative step, and then the same 
cofactor was used in a reductive step. This mechanism 
appeared to be very similar to the mechanism for the 
conversion of cholesterol to coprostanol (Bjorkhem and 
Gustafsson, 1971). 
An enzyme system that is closely related to 
7-dehydroxylase is 21-dehydroxylase. A strain of Eubacterium 
lentum was isolated from human feces that catalyzed the 
21-dehydroxylation of 11-deoxycorticosterone to progesterone 
(Feighner et al., 1979). The enzyme had a broad pH range 
with an optimum of 6.4 to 6.8. In crude cell extracts, 
activity was rapidly and irreversibly inhibited by 
atmospheric oxygen (Feighner and Hylemon, 1980). Extracts 
that were stored anaerobically under argon gas at 4°C lost 
over 40% of their activity within 48 hours. When glycerol or 
reduced glutathione was added to the crude extracts, the 
activity was partially stabilized. This stabilization was 
not observed when 2-mercaptoethanol or L-cysteine was added. 
Regardless of the addition of glycerol or reducing agents, 
all activity was lost after 5 days. Anaerobically dialyzed 
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cell extracts required both a reduced pyridine nucleotide 
(NADH or NÀDPH) and an oxidized flavin (FAD or FMN). It was 
observed that an NAD(P)H:FMN oxidoreductase provided reduced 
flavin for the 21-dehydroxylase. These two enzymes were not 
physically associated and were regulated by independent 
control systems. Sparging washed whole cell suspensions with 
hydrogen gas increased 21-dehydroxylase activity 35-fold. 
Preliminary evidence indicated that an oxygen-labile 
hydrogenase was present in whole cells and cell extracts. It 
was thought that the 21-dehydroxylase was located on the 
membrane or that there was a neutral steroid transport system 
in the E. lentum strain studied. 
Another enzyme system that has been studied and may have 
similarities to the cholesterol reductase system is 
7a-hydroxysteroid dehydrogenase. This enzyme is known to 
occur in Escherichia coli, Bacteroides fragilis, Clostridium 
absonum, Clostridium limosum, and Brevibacterium fuscum 
(Prabha et al., 1989). 7a-Hydroxysteroid dehydrogenase was 
purified from E. coli and characterized (Prabha et al., 
1989). This enzyme had a broad specificity but required bile 
acids that had a hydroxyl group at the C-7 position. NAD"*" 
was used as a cofactor. Although the enzyme did not require 
metal ions, there was increased activity in the presence of 
Na*, k"^, Ca^"*", and Mn^"*". Detergents and oxidizing groups 
were inhibitory to the enzyme, and reducing agents were 
stimulatory. 
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A lecithinase-lipase-negative Clostridium sp. was shown 
to have NADP-dependent 35-, 7a- and 7B-hydroxysteroid 
dehydrogenase activities (Edenharder et al., 1989). All 
three dehydrogenases could be detected in the supernatant and 
membrane fractions after solubilization with Triton X-100, 
suggesting that the enzymes were membrane bound. The 
35-hydroxysteroid dehydrogenase had a pH optimum of 7.5 and 
was synthesized constitutively. A molecular weight of 104000 
was estimated by molecular sieve chromatography. In 
cell-free extracts, activity could easily be demonstrated in 
the reductive direction by using a 3-keto substrate. 
However, it was not possible to demonstrate the oxidation of 
36-hydroxy bile acids. No special precautions to exclude 
oxygen were necessary during the preparation of the crude 
cell extract or the enzyme assay. The activity of the 
extract was unchanged when stored at 4°C for up to 3 h. 
Activity was still detectable after 48 h of storage at 4°C. 
Reducing agents stabilized the enzyme, while EDTA had no 
effect. Activities of 7a- and 76-hydroxysteroid 
dehydrogenases required induction. The Clostridium sp. 
studied showed oxidative activity of 7a-hydroxysteroid 
dehydrogenase, but extracts could only be demonstrated to 
work in the reductive direction. The 7B-hydroxysteroid 
dehydrogenase also would only reduce a 7-keto group when in a 
cell-free extract. The authors could not explain why enzymes 
that exhibited reversible oxidation-reduction activities in 
vivo were shown to be irreversible in vitro. 
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A 7a-hydroxysteroid dehydrogenase was purified from 
Eubacterium 12708. The enzyme was a tetramer of identical 
subunits, with a molecular weight of approximately 124000. 
The enzyme was NADP-dependent, was inhibited by sulfhydryl 
reactive compounds, and was not affected by metal ion 
chelators (Franklund et al., 1990). 
76-Hydroxysteroid dehydrogenase activity was 
demonstrated in a strain of Eubacterium aerofaciens (Hirano 
and Masuda, 1982). A crude cell extract was prepared by 
sonicating the bacteria, and the enzyme was partially 
purified by column chromatography. All the steps subsequent 
to growing the bacteria were done aerobically. The enzyme 
was dependent on NADP"*" as a cofactor and was expressed 
constitutively. An optimum pH of 10.5 and a molecular weight 
of 45000 were determined. Enzyme activity was stabilized 
when dithiothreitol or thioglycolate was added to the 
reaction mixture, and the addition of sulfhydryl inhibitors 
such as p-chloromercuribenzoate or iodoacetate abolished 
enzyme activity. Divalent cations or EDTA had no effect on 
enzyme activity. 
Two strains of Eubacterium sp. were isolated that 
catalyzed the 16a-dehydroxylation-reduction of 
16a-hydroxysteroids to form 17-iso-steroids (Bokkenheuser et 
al., 1980). This system appeared to be comprised of two 
enzymes, a 16a-hydroxyprogesterone dehydroxylase and a 
16-dehydroprogesterone reductase (16-DHPR) (Winter et al., 
1982). Using resting cells, it was determined that 16-DHPR 
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activity was stimulated by hemin, hydrogen, or pyruvate 
(Glass and Burley, 1985). When hydrogen or pyruvate were 
present, the Eubacterium sp. also reduced the delta-4 double 
bond of progesterone and dehydroxylated the 3a-hydroxy group. 
It was thought that, in this bacterium, hemin was used in an 
electron transport system that supplied electrons to 16-DHPR 
that was coupled to the oxidation of pyruvate and hydrogen. 
A cell-free extract with 16-DHPR activity was obtained 
from a Eubacterium sp. (Watkins and Glass, 1991). Anaerobic 
precautions were taken during the growth, harvesting, and 
breakage of the bacterium. The activity was inducible and 
required a steroid with a delta-16 double bond and a C-20 
ketone. When pyruvate was used as an electron donor, 
coenzyme A and methyl viologen were required for 16-DHPR 
activity. It was determined that a pyruvate:methyl viologen 
oxidoreductase oxidized pyruvate to generate reduced methyl 
viologen that supplied electrons to 16-DHPR. Flavins or 
NAD(P)H could not replace pyruvate as electron donors. 
16-DHPR activity was found in both the cytoplasmic and 
membrane fractions of crude cell extracts; however, the 
specific activity was approximately twice as high in the 
membrane fraction as in the cell extracts. The 16-DHPR 
activity was stable for at least one week when stored 
anaerobically at 0°C. When attempts were made to solubilize 
16-DHPR from the membrane with Triton X-100, all activity was 
lost. The pyruvate :methyl viologen oxidoreductase activity 
was detected in the cytoplasm but not in the membrane 
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fraction. The 16-DHPR had a very broad pH optimum that 
extended from 5.0 to 8.0. The highest enzyme activity was 
obtained when the reaction mixture contained 10% methanol. 
The activity was inhibited by dithiothreitol. 
Desmolase is another steroid-altering enzyme that has 
been demonstrated in a Eubacterium sp. A bacterium that was 
classified as Eubacterium desmolans was isolated from cat 
feces (Morris et al., 1986). This bacterium synthesized a 
desmolase that cleaved the side chain of l7a-hydroxysteroids 
between C-17 and C-20. It also produced a 208-hydroxysteroid 
dehydrogenase that reduced the keto group at C-20. 
In summary, in addition to cholesterol reductase 
activity, eubacteria or eubacteria-like organisms have been 
shown to have the following activities against steroids: 
7a-dehydroxylase (White et al., 1980), delta-6 reductase 
(White et al., 1982), 21-dehydroxylase (Peighener et al., 
1979), 7a-hydroxysteroid dehydrogenase (Franklund et al., 
1990), 76-hydroxysteroid dehydrogenase (Hirano and Masuda, 
1982), 16a-dehydroxylase, 16-dehydroprogesterone reductase, 
progesterone delta-4 reductase, 3a-dehydroxylase 
(Bokkenheuser et al., 1980), and desmolase and 
20B-hydroxysteroid dehydrogenase (Morris et al., 1986). Most 
of the strains that acted on a particular substrate did not 
need the substrate for growth, and growth was often not 
enhanced by the addition of the substrate to the growth 
medium. The reason that these organisms produce such an 
array of specialized enzymes, many of which are constitutive. 
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is not known (Glass et al., 1979; Morris et al., 1986). 
Eubacteria 
The word "eubacterium" is derived from the Greek words 
for beneficial bacterium. In the context of this review, it 
is used to designate a bacterial genus. The genus name 
should not be confused with the other common usage of the 
word, which denotes the eubacterial kingdom. In that 
context, it stands for the kingdom of "true" bacteria in 
contrast to another kingdom of bacteria, called 
archaebacteria. 
Members of the genus Eubacterium are nonsporing. 
Gram-positive rods that are obligately anaerobic and 
chemoorganotrophic. Eubacteria produce mixtures of organic 
acids from carbohydrates or peptones. The most common acidic 
end products are butyric, acetic, and/or formic acids. 
Eubacteria do not produce propionic or lactic acid as the 
major end product, or succinic acid with lactic acid and 
small amounts of acetic or formic acids in the presence of 
COg. They also do not produce acetic and lactic acids as the 
major end products. The production of acidic end products is 
the major differentiating factor that distinguishes the genus 
Eubacterium from the closely related genera 
Propionibacterium, Lactobacillus, Actinomyces, and 
Bifidobacterium (Moore and Moore, 1984). 
I 
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Eubacteria have been isolated from cavities of man and 
other animals, plant and animal products, soft tissue 
infections, and soil. Their sensitivity to oxygen varies, 
and many strains need to be cultivated on prereduced media. 
The optimal growth conditions include an incubation 
temperature of 37°C and a pH near neutrality (Moore and 
Moore, 1984). In the human intestine, eubacteria are usually 
found in concentrations of 10^ to 10^^ per ml of fecal 
material (Goldin, 1986). They are rarely found in the 
stomach, jejunum, or ileum and exist primarily in the colon. 
In a study of the anaerobic fecal flora of the baboon, 
Brinkley and Mott (1978) enumerated 3.3 X 10^° eubacteria per 
gram of dry fecal matter. These bacteria comprised 16.7% of 
the total number of viable organisms recovered. 
Technologies for Reducing Cholesterol in Foods 
As the consumer demand for reduced-cholesterol foods 
increases, industries are investigating several methods for 
supplying this demand. One of the new methods that is just 
beginning to be used is steam-stripping. This process uses 
steam distillation to remove greater than 90% of cholesterol 
from butter oil and lard (Sperber, 1989). This process will 
have few regulatory problems and should be relatively 
inexpensive, making it one of the best candidates for 
widespread use in the near future. 
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Supercritical CO^ extraction is a process that has been 
used for many years for various purposes, such as the 
extraction of caffeine from coffee. In this type of 
extraction, a very high pressure at relatively low 
temperatures is used to bring a material into a supercritical 
state. When CO^ is in this state, it behaves both as a 
liquid and as a gas, and it dissolves cholesterol in foods. 
This process has been used to reduce cholesterol levels in 
butterfat by up to 98% (Sperber, 1989). The greatest 
challenge in applying this technology is in developing 
cost-efficient methods to treat foods on an industrial scale. 
Enzymes have been used to treat foods since ancient 
times. The uses included the production of fermented 
liquors, leavened bread, the conversion of milk to curds and 
whey, and meat tenderization with papain from papaya fruit 
and tree leaves (reviewed by Neidleman, 1991). Some of the 
more important enzymes used in the food industry today 
include amylases, proteases, glucose oxidase, pectinase, 
hemicellulase, invertase, rennin, lipase, catalase, and 
lactase. When compared to chemical processes, enzymatic 
methods are less harsh, form fewer by-products, are easier to 
control, and are considered "natural" by the consumer. 
To date, very little research has been done on 
enzymatically reducing the cholesterol content of foods. 
Besides our current work on cholesterol reductase (Dehal et 
al., 1991; Freier and Hartman, 1991), the only publications 
known to this author on the subject of enzymatic reduction of 
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food cholesterol involved cholesterol oxidase. 
The isolation of bacteria from soil with the ability to 
oxidize cholesterol was first accomplished by Turfitt (1944). 
He demonstrated that nocardiae were the predominant 
cholesterol oxidizers in soil. A very broad range of aerobic 
bacteria have been shown to have cholesterol oxidizing 
abilities. A Streptomyces sp. was isolated on a medium that 
contained cholesterol as the sole carbon source (Brown and 
Peterson, 1966). It was able to utilize 80 to 100% of the 
cholesterol in a 0.1% cholesterol medium within 6 d. Most of 
the carbon in cholesterol was converted to COg, but some 
appeared in the cellular material. More recently, 726 
cholesterol-degrading bacteria were isolated and compared 
taxonomically (Ferreira and Tracey, 1984). The majority of 
the cholesterol oxidizers were classified as Rhodococcus 
spp., and a few as Mycobacterium spp. and Nocardia spp. 
The first attempt to use cholesterol-oxidizing bacteria 
to reduce the cholesterol content of a food was made by 
Aihara et al. (1988). A strain of Rhodococcus equi that had 
been isolated from butter was grown in a minimal medium. 
Sterile egg yolk was added to this medium in various 
concentrations, ranging from 0.3 to 1.7 mg per ml. 
Cholesterol degradation was then monitored by thin-layer 
chromatography. After 3 d of incubation, the cholesterol 
content of the medium had decreased, but, at concentrations 
above 0.9 mg of egg yolk per ml, the degradation was 
incomplete. The only detectable intermediate was 
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4-cholesten-3-one, and the authors suggested that the 
cholesterol was rapidly converted to nonsteroid compounds 
with almost no accumulation of steroid intermediates. 
Several strains of cholesterol-oxidizing bacteria were 
compared for their ability to rapidly degrade cholesterol 
with no accumulation of intermediates (Johnson and Somkuti, 
1990). It was observed that, when cholesterol was introduced 
to an actively growing strain of R. equi, it was rapidly 
degraded with no accumulation of intermediates. If resting 
cells were used, 4-cholesten-3-one and 
l,4-cholestadiene-3-one and other unidentified intermediates 
were detected. The oxidation enzyme system was stimulated by 
the presence of cholesterol in the growth medium but was 
constitutively expressed. Cell-free extracts were prepared 
by sonication from the most efficient cholesterol-degrading 
strains. The most efficient extract could degrade up to 9.4 
Hq of free cholesterol per minute per mg protein. However, 
when this extract was incubated with egg yolk cholesterol, 
only 1.9 nq of cholesterol was degraded per minute per mg 
protein. The investigators believed that the 
cholesterol-degrading enzymes may have had a limited 
accessibility to the egg yolk cholesterol. Up to 40% of the 
egg yolk cholesterol was degraded by an extract after 1 h of 
incubation. Using cholesterol in cream as the substrate, 
only 2.4% of the cholesterol was degraded in 1 h; 7.0% was 
degraded after 15 h. It was concluded that more data are 
needed on the toxicity of the products generated by 
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cholesterol-oxidizing systems. In addition, the system 
studied could not realistically be used to reduce the 
cholesterol content of foods unless more efficient enzymes or 
better ways of making the cholesterol accessible to the 
enzymes are developed. 
There are several ways that enzymatic reactions 
involving water-insoluble substrates can be made more 
efficient. When a cell paste of a cholesterol-oxidizing 
Nocardia sp. was suspended in carbon tetrachloride, 
cholesterol was converted to 4-cholesten-3-one at a more 
rapid rate than when the reaction was carried out in an 
aqueous system (Buckland et al., 1975). The cells could be 
easily seperated from the reaction mixture and reused several 
times. 
Kazandjian and coworkers (1986) developed a system for 
the determination of cholesterol concentrations in an organic 
solvent system. They coupled peroxidase with cholesterol 
oxidase and tested for activity in a toluene solvent system. 
They determined that activity was maintained by both enzymes. 
Yoshimoto et al. (1987) modified cholesterol oxidase with a 
synthetic copolymer of polyoxyethylene allylmethyldiether and 
maleic acid anhydride. This modified enzyme was soluble in 
organic solvents. In benzene, the modified cholesterol 
oxidase formed 4-cholesten-3-one with an activity of 0.6 /xmol 
per min per mg protein. 
Many enzymes have increased activities in water-organic 
solvent two-phase systems. Several hydroxysteroid 
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dehydrogenases had greatly increased activities in two-phase 
systems consisting of ethyl acetate or butyl acetate in an 
aqueous buffer (Carrea et al., 1988). A very efficient 
system was devised for hydroxysteroid dehydrogenases that 
consisted of immobilized enzyme, a two-phase buffer, and an 
NAD(P)(H)-regenerating system. 
Another type of system that has been recently developed 
for the enzymatic conversion of water-insoluble substrates is 
the detergentless microemulsion. This system consists of a 
hydrocarbon, isopropanol, and water (Khmelnitsky et al., 
1988). When cholesterol oxidase was tested in a 
detergentless microemulsion, large quantities of cholesterol 
were converted to 4-cholesten-3-one with 100% yield. The 
separation of reaction product and the regeneration of enzyme 
were easily accomplished. 
The activities of steroid-reactive enzymes can be 
greatly increased in organic solvent-containing systems. 
Unfortunately, most of these systems use chemicals that are 
toxic or carcinogenic and would not be ideal for the 
treatment of foods. Supercritical CO^ is a much more viable 
option. COg has a critical temperature of 31.1°C, which is a 
suitable temperature for treating most biochemicals. 
Proteins are insoluble in supercritical COg, so enzymes are 
easily removed from the reaction. CO^ is inert, inexpensive, 
and nontoxic, making it an excellent candidate for food 
treatment. Randolph et al. (1988) showed that cholesterol 
oxidase was active in supercritical COg and that nearly 100% 
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of the cholesterol in their preparations was converted to 
4-cholesten-3-one within 1 h. 
There are also several other ways that an enzymatic 
conversion of cholesterol could be made more efficient. When 
resting cells of a cholesterol-oxidizing strain of 
Rhodococcus erythropolis were irradiated with a low level of 
ultrasonic energy, the kinetic rates of biotransformation 
were significantly enhanced (Bar, 1988). Another way 
cholesterol conversion could be improved is by using 
immobilized cells. Sonomoto et al. (1982) achieved increased 
activity and stability of lla-hydroxylation of progesterone 
when Rhizopus stolonifer mycelia were entrapped in a 
photo-crosslinked resin. Tiny magnetic particles were used 
to immobilize a cholesterol side-chain degrading 
Mycobacterium sp. (Flygare and Larsson, 1987). This allowed 
the repeated use of the bacterial cells, because cells could 
be retrieved from the reaction mixture with a magnet. 
An immobilized cell method was developed for a 
continuous steroid reduction by a strict anaerobe (Abramov et 
al., 1990). Cells of Clostridium paraputrificum were 
immobilized in polyacrylamide-hydrazide beads. The 
gel-entrapped cells could tolerate the presence of up to 30% 
ethylene glycol that was added as a cosolvent. A system was 
optimized that could continuously reduce 
1,4-androstadiene-3,17-dione to its 3-keto-5B and 
3a-hydroxy-5B products with a yield of 98% for at least 120 
h. It is possible that a similar technique could be used to 
reduce cholesterol to coprostanol in foods. 
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PART I. ISOLATION OF CHOLESTEROL-REDUCING BACTERIA 
Introduction 
To date, a total of 13 cholesterol-reducing bacteria 
(CRB) have been isolated and characterized (Eyssen et al., 
1973; Sadzikowski et al., 1977; Mott and Brinkley, 1979; 
Brinkley et al., 1982). All of these bacteria have been 
classified as strains of Eubacteria sp. All of the strains 
were isolated from the fecal contents of rats, humans, or 
baboons. 
Two methods have been used to isolate CRB. The first 
method employed enrichment in cholesterol-containing media, 
repeated dilution to extinction of coprostanol-producing 
cultures, filtration, and use of selective agents (Eyssen et 
al., 1973; Sadzikowski et al., 1977; Mott and Brinkley, 
1979). These methods were used because the CRB did not form 
colonies on any type of plating medium that was tried. The 
second method involved using an anaerobic chamber to plate 
dilutions of samples on a solid medium that contained a high 
level of cholesterol homogenized with brain tissue (Brinkley 
et al., 1982). 
Because of the methods used and the sources that were 
sampled, most of the characterized strains of CRB had similar 
properties. The bacteria required strict anaerobic 
conditions for growth, and all but two strains required a 
plasmalogen (plasmenylethanolamine) to reduce cholesterol to 
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coprostanol (Brinkley et al., 1982). Many of the strains 
also had an obligate requirement for cholesterol or a related 
sterol for growth (Eyssen et al., 1973; Sadzikowski et al., 
1977; Mott and Brinkley, 1979). The CRB grew slowly, and 
they formed colonies on solid media poorly or not at all. 
Because previously isolated strains of CRB were very 
fastidious, common laboratory procedures could not be used to 
study them. The growth media that were used contained brain 
or insoluble lipids that interfered with obtaining a clean 
bacterial pellet after centrifugation. The cultures did not 
form colonies on agar plates, making reisolation and 
enumeration difficult. For these reasons, various methods 
for producing clear media that may sustain CRB were 
formulated, and new enrichment and isolation techniques were 
combined with more diverse sample types to isolate bacteria 
with better characteristics. 
Several methods to solubilize cholesterol were tested. 
Cholesterol has been esterified with adipic acid and reacted 
with polyethylene glycol to yield a water-soluble derivative 
(Proksch and Bonderman, 1978). Many investigators have used 
cholesterol-lecithin vesicles or liposomes as the source of 
cholesterol for cholesterol-requiring bacteria (Kahane and 
Razin, 1977; Stanton, 1987). Cyclodextrins are doughnut-
shaped molecules composed of 6 to 8 glucose units linked by 
a-1,4-glycosidic bonds. Cyclodextrins have been used to 
solubilize sterols (Hesselink et al., 1989; Bar, 1990); when 
hydrophobic molecules such as cholesterol enter a hydrophobic 
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cavity within the cyclodextrin, they become much more soluble 
in water. 
Several different plating methods were used to obtain 
isolated colonies. Typically, plating media contain agar as 
the solidifying agent. However, some bacteria are inhibited 
by agar. Gelrite (Schweizerhall, Inc., South Plainfield, NJ) 
is an agar substitute, composed of gellan gum from 
Pseudomonas clodea, that has been used for the cultivation of 
bacteria that are inhibited by agar (Harris, 1985). Solid 
plating media for anaerobes are usually either poured into 
petri plates that are incubated in anaerobic chambers or jars 
or made into roll tubes (Holdeman et al., 1977). Another 
technique is to contain a solid medium in specially 
constructed bottles under an oxygen-free atmosphere (Hermann 
et al., 1986). This latter method is called the Wolfe bottle 
technique. 
Certain compounds have been shown to be stimulatory to 
the growth of various stains of Eubacterium spp. or to 
promote coprostanol production. L-Arginine and L-lysine 
stimulated the growth of Eubacterium nodatum, Eubacterium 
timidum, and Eubacterium brachy (Hill et al., 1987). 
Riboflavin enhanced the 7a-dehydroxylase activity of a 
Gram-positive intestinal anaerobe (Masuda et al., 1983). 
Glycyrrhizin and p-nitrophenyl-mono-B-D-glucuronide (pNPG) 
stimulated the growth of Eubacterium sp. strain GLH when 
grown in a carbohydrate-free medium (Akao et al., 1988). 
When CaClg was added to the diet of rats, the percentage of 
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coprostanol in the feces increased (Wells and Cooper, 1958). 
Brinkley et al. (1982) observed that pyruvate stimulated CRB. 
Selective agents and various media formulations were 
tested for their ability to inhibit the background flora. 
Watanabe et al. (1986) used a medium that contained 
cholesterol as the sole carbon source to enrich for and 
isolate cholesterol-oxidizing bacteria. Bile salts have been 
used to selectively inhibit non-enteric bacteria. 
Deoxycholic acid inhibits flagellation and swarming in 
Proteus spp. (D'Mello and Yotis, 1987). Bile salts also 
increased the cholesterol uptake of a strain of Lactobacillus 
acidophilus under anaerobic conditions (Gilliland et al., 
1985). Snog-Kjaer and coworkers (1956) observed that 
coprostanol is formed by mixed cultures of bacteria in the 
presence of 0.15 mg per ml CuSO^, a compound that is 
inhibitory to many microbes. Sadzikowski et al. (1977) used 
0.5% phenethyl alcohol to eliminate Gram-negative rods that 
were present in a mixed cholesterol-reducing culture. This 
compound has also been used to inhibit the swarming of 
Proteus spp. (Kopp et al., 1966). A cholesterol-reducing 
Eubacterium sp. was capable of growing in media containing 
clindamycin, 1.6 ng per ml; erythromycin, 3 fig per ml; and 
penicillin, 2 U per ml (Sadzikowski et al., 1977). 
New methods and sample sources were used to isolate 
novel cholesterol-reducing bacteria with characteristics that 
may make industrial-scale food treatment possible. 
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Materials and Methods 
Bacteria 
Eubacterium ATCC 21408 (Eyssen et al., 1973) and 
Eubacterium sp. from rats and Eubacterium sp. from a human 
(Sadzikowski et al., 1977) were obtained from the culture 
collection of the Virginia Polytechnic Institute and State 
University. The bacteria were transferred every two weeks 
into an anaerobic brain-containing medium. Mixed cultures 
and pure cultures of new isolates of cholesterol-reducing 
bacteria were maintained by weekly transfers in base 
cholesterol plus CaClg (BC) medium. 
Growth media 
Standard brain medium (SBM) was prepared as described by 
Brinkley et al. (1982), except it was boiled under gas 
that was purified by passage through a column of heated 
copper (Hungate technique) as described by Holdeman et al. 
(1977). The medium was cooled, dispensed to 16 X 100 mm 
culture tubes (9 ml per tube), sealed with butyl rubber 
stoppers, placed in a press, and sterilized in an autoclave 
at 121°C for 15 min. Standard pork brain (SPB) medium was 
prepared as described by Sadzikowski (1977) except that it 
was boiled, dispensed, and sterilized in the same manner as 
SBM. Thioglycolate medium with brain (TMB) contained per 
liter: thioglycolate medium without dextrose or indicator 
(Difco, Detroit, MI), 24 g; lyophilized pork brain, 30 g; 
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yeast extract (Difco), 10 g; sodium thioglycolate, 1.3 g; and 
resazurin, 1 mg. TMB was homogenized in a Waring blender 
(Waring Products piv., New Hartford, CT) for 5 min under a 
stream of gas and then prepared anaerobically in the same 
manner as SBM. Several compounds were added to TMB medium to 
test for increased coprostanol production by CRB. These 
included the following (per liter): 0.5 g of 
cysteine'HCl'HgO substituted for sodium thioglycolate, 93 mg 
of riboflavin, 5 g of L-lysine, 5 g of L-arginine, and 50 mM 
potassium phosphate buffer, pH 7.0. 
A base cholesterol medium (BM) was prepared as described 
by Brinkley and Mott (1982) except that cholesterol and 
lecithin were homogenized in distilled, purified water (dHgO) 
in a Waring blender under a stream of gas, the other 
components were added, and then the medium was prepared 
anaerobically in a manner similar to SBM. 
Plasmenylethanolamine was not added. BM contained the 
following components per liter: lecithin (type IV-S, Sigma 
Chemical Co., St. Louis, MO), 1 g; cholesterol, 2 g; 
casitone, 10 g; yeast extract, 10 g; sodium thioglycolate, 
0.5 g; KgHPO^, 40 mg; KHgPO^, 40 mg; and resazurin, 1 mg. 
The pH was adjusted to 7.2 with 3 N KOH before boiling. 
The efficiency of coprostanol production was tested with 
mixed cultures grown in several modifications of BM. BM was 
prepared with and without each of the following: potasium 
phosphate buffer, sodium pyruvate, sodium formate (0.4 g per 
liter), sodium selenite (0.17 mg per liter), and calcium 
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chloride (0.1 g per liter). BM was also inoculated and added 
to tubes containing Tween 80 (Fisher Scientific Co., Fair 
Lawn, NJ) as described by Holdeman et al. (1977). In 
addition, various concentrations of sodium formate (0.04 g to 
8.4 g per liter) and of CaCl2*2H20 (0.01 g to 100 g per 
liter) were tested. BM that contained 1 g per liter 
CaCl2*2H20, and that did not contain potassium phosphate 
buffer, was called BC medium. BM was prepared with each of 
the following: 1.2 mM glycyrrhizin (Sigma), 2.4 mM 
p-nitrophenol mono-8-D-glucuronide (pNPG; Sigma), or 10 ml 
per liter VPI hemin solution with 200 fil per liter VPI 
vitamin solution (Holdeman et al., 1977). 
To test for the conversion of sterols other than 
cholesterol by mixed cultures of CRB, the following sterols 
(Sigma) were substituted for cholesterol in BM: 
stigmosterol, ergosterol, androstenedione, and 
4-cholesten-3-one. 
Thioglycolate medium with cholesterol (TC) contained the 
same concentration of homogenized lecithin and cholesterol as 
BM, but contained (per liter): Thioglycolate Medium without 
dextrose or indicator (Difco), 24 g; sodium pyruvate, 0.5 g; 
and resazurin, 1 mg. After the pH was adjusted to 7.2, the 
medium was heated to boiling in a microwave oven, dispensed 
to screw-capped tubes, and sterilized. Just before 
inoculation, TC tubes were steamed 5 min in an autoclave or 
were placed in boiling water for 5 min to partially drive off 
oxygen and rapidly cooled to 37°C. 
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Supplemented brain-heart-infusion broth (BHI-S) 
contained the following components (per liter): BHI broth 
(Difco), 37 g; yeast extract, 5 g; resazurin, 1 mg; 
cysteine'HCl'HgO, 0.5 g; VPI hemin (Holdeman et al., 1977), 1 
ml; and VPI vitamin (Holdeman et al., 1977), 0.2 ml. 
BHI-S broth was prepared anaerobically by using the same 
method as was used for SBM. The cysteine, hemin solution, 
and vitamin solution were added after boiling. Medium MIO 
was prepared as modified by Brinkley and Mott (1978), except 
it was used as a broth that was made by using Hungate 
techniques (Holdeman et al., 1977). MIO medium was also 
prepared with homogenized cholesterol (0.2%) and lecithin 
(0.1%). Peptone yeast extract (PY) and PY plus glucose (PYG) 
media were prepared as described in the Anaerobe Laboratory 
Manual (Holdeman et al., 1977). 
Clear cholesterol-containing media 
Various methods of producing clear cholesterol-
containing media that would support the growth of CRB were 
formulated. A roll-tube medium that contained 
polyoxyethanyl-cholesteryl sebacate (water-soluble 
cholesterol, Sigma) was prepared (WSRT). This medium 
contained the following components per liter: water-soluble 
cholesterol, 4 g; Casamino Acids (Difco), 8 g; Folch Brain 
Extract (Sigma), 0.8 g; yeast extract, 8 g; KgHPO^, 4 g; 
agar, 16 g; and resazurin, 1 mg. The medium was boiled 5 min 
under Og-free Ng gas and tempered to 46°C. Cysteine•HCl•H2O 
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was added (400 mg). The medium was dispensed to roll tubes 
that were sealed with butyl rubber stoppers, placed in a 
press, and sterilized in an autoclave for 15 min at 121°C. 
Roll tubes were then made as described by Holdeman et al. 
(1977). 
A liposome-containing medium (LIP) was prepared by 
dissolving lecithin (97% phosphatidyl choline, Behring 
Diagnostics, La Jolla, CA), 916 mg; cholesterol (Sigma), 200 
mg; sodium cholate (Sigma), 760 mg; and Folch Brain Extract 
(Sigma), 18 mg, in 30 ml of 95% ethanol. The ethanol was 
evaporated under a stream of Ng gas. Distilled water (dHgO), 
220 ml, was added, and the mixture was sonicated for 5 min at 
100 watts (Braun-sonic 1510, B. Braun Co., Melsungen). The 
following components (base medium) were then added: Casamino 
Acids, 2 g; yeast extract, 2 g; KgHPO^, 1 g; sodium 
thioglycolate, 0.1 g; and resazurin, 0.2 mg. The pH was 
adjusted to 7.2, and the medium was boiled, dispensed, and 
sterilized in the same manner as for SBM. 
Supplemented proteose peptone broth (SPP) was prepared 
in the manner described by Hill et al. (1987) for the growth 
of Eubacterium spp., except a sterile liposome preparation 
was substituted for horse serum. The liposomes were prepared 
by evaporating 3 ml of 50% plasmalogen phosphatidyl 
ethanolamine (Sigma) under gas in a flask. Three grams of 
water-soluble cholesterol (Sigma) dissolved in 60 ml dHgO was 
added, and the flask was agitated until the lipids were 
suspended. The liposomes were filtered through a 0.22 /xm 
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pore size syringe filter (Costar Corp., Cambridge, MA), 
bubbled aseptically with gas for 30 min, and added to 
sterile, reduced SPP (940 ml) to produce SPPL broth. 
A thioglycolate medium with liposomes (T-LIP) was 
formulated. Cholesterol, 200 mg, and phosphatidylcholine 
(97% pure, Behring Diagnostics), 440 mg, were dissolved in 5 
ml of chloroform and placed in a screw-capped vial. The 
solvent was evaporated under a stream of gas, 10 ml dHgO 
were added, and the vial was sonicated in a water bath 
sonicator for 15 min. This liposome preparation was added to 
the following components dissolved in 100 ml of dHgO: 
Thioglycolate Medium without dextrose or indicator (Difco), 
4.8 g; yeast extract, 2 g; sodium thioglycolate, 0.2 g; and 
resazurin, 0.1 mg. The medium was reduced and sterilized as 
described for SBM. 
A medium containing an albumin emulsion of cholesterol 
and oleic acid (ACQ; Treadwell and Vahouny, 1977) was 
prepared. Phosphatidyl ethanolamine containing 50% 
plasmalogen (Sigma), 5 ml, was evaporated in a test tube 
under a stream of gas. Oleic acid, 5 ml, was added and 
the tube was mixed on a vortex mixer until the lipid was 
dissolved. Cholesterol, 0.4 g, was added, and the mixture 
was bubbled with Ng gas for 20 min. Albumin (Bovine, 
Fraction V, Sigma), 0.4 g, was added and the emulsion was 
mixed on a vortex mixer. The other components of the base 
medium (as described above for LIP medium) were dissolved in 
220 ml dHgO, and slowly added to the cholesterol emulsion 
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with stirring. The medium was boiled, dispensed, and 
sterilized by using the same method as for SBM. 
A medium was prepared that contained B-cyclodextrin: 
cholesterol (2:1 molar ratio) in base medium (CDBM), prepared 
anaerobically. The B-cyclodextrin (Sigma), 1.2 g, was 
dissolved with the other components in 100 ml of dHgO. 
Cholesterol, 0.2 g, dissolved in 3 ml of 95% ethanol, was 
added in a dropwise manner to the stirred medium. The 
complete medium was then boiled under gas, dispensed to 
tubes, and sterilized. 
Serum contains a large amount of cholesterol that is 
soluble in water. When serum was boiled to drive off oxygen, 
a precipitate formed. To avoid precipitation, an anaerobic 
serum-containing medium was formulated by using Oxyrase 
(Oxyrase, Inc., Ashland, OH) to eliminate the need to boil 
the medium to attain a low oxidation-reduction potential. 
The medium (SOT) contained the following components; 
Thioglycolate Medium without dextrose or indicator (Difco), 
4.8 g; yeast extract, 2 g; sodium thioglycolate, 0.25 g; 
resazurin, 0.2 mg; and dHgO, 100 ml. After the medium was 
sterilized in an autoclave and cooled to room temperature, 
100 ml of sterile, inactivated fetal bovine serum (Hazelton 
Research Products, Denver, PA), and 0.33 ml of Oxyrase were 
added, and the flask was sealed with a rubber stopper. The 
medium was incubated overnight at 37°C and was then dispensed 
to sterile tubes under gas. 
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Ex-Cyte I (Miles, Inc., Kankakee, IL) is a sterile 
bovine lipoprotein medium supplement that contains 10 mg per 
ml cholesterol in aqueous solution. Ex-Cyte I Lactose 
Pyruvate (XLP) medium contained the following components per 
liter: Casitone, 10 g, yeast extract, 5 g, sodium 
thioglycolate, 0.5 g, CaClg'ZHgO, 0.1 g, and resazurin, l mg. 
This medium was boiled under gas, cooled, sealed in a 
flask, sterilized, and cooled to room temperature. A 
solution containing 5 g of sodium pyruvate and 5 g of lactose 
dissolved in 35 ml dHgO was filter-sterilized by using a 0.22 
urn syringe filter and was added to 20 ml of Ex-Cyte I in a 
sterile flask. This mixture was bubbled with sterile Ng gas 
for 30 min and then aseptically added to the other sterile, 
reduced medium components. 
Isolation media 
An anaerobic medium (IC) was formulated that contained 
cholesterol as the sole carbon source. This medium was 
similar to medium I of Watanabe et al. (1986) that was used 
aerobically to enrich for cholesterol-oxidizing bacteria. 
One liter contained: NH^Cl, 1 g; KgHPO^, 0.25 g; MgSO^»7H20, 
0.25 g; NaCl, 5 mg; FeSO^, 0.5 mg; and cholesterol, 1 g. The 
pH was adjusted to 7.0; the medium was homogenized with a 
Waring blender and boiled under gas. After cooling, 2.5 
ml of a 10% solution (w/v) of NagS'SHgO was added; the medium 
was dispensed to tubes and sterilized in the same manner as 
was used for SBM. 
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BHI-S was modified by the addition of Oxgall (Difco) at 
a concentration of 3 g per liter and cholesterol at 2 g per 
liter (BHI-SOC). Oxgall and cholesterol were homogenized in 
dHgO in a Waring blender. This homogenate was then added to 
the remaining components, and the medium was prepared as 
described above for BHI-S. Oxgall and cholesterol were added 
in a similar manner to AC broth (Difco) that was then 
prepared (aerobically) according to the manufacturer's 
instructions (AC-OC). Oxgall was also added (0.5%, w/v) to 
SPB broth (SPBO). 
Batches of TMB medium were made that contained one of 
the following: CuSO^, 0.15 mg per ml; phenethyl alcohol, 
0.5%; clindamycin, 1.6 /ig per ml; erythromycin, 3 jug per ml; 
and penicillin, 2 U per ml. Phenethyl alcohol (0.5%) was also 
added to BM broth plus 0.5% sodium pyruvate. 
To screen for possible cholesterol-reducing 
lactobacilli, MRS broth (Difco) was prepared according to the 
manufacturer, except that it was made anaerobically and with 
the addition of Oxgall and cholesterol (MRS-OC) by using the 
same method as for the preparation of BHI-SOC. 
Cysteine'HCl'HgO was added (0.5 g per liter) after boiling. 
LBS broth (Difco) was also prepared with the addition of 
Oxgall, cholesterol, and cysteine (LBS-OC). 
Several media and methods were adopted for the isolation 
of CRB by using solid anaerobic media. Cholesterol brain 
agar (CBA) was prepared according to Brinkley and coworkers 
(1980). This medium was made aerobically, sterilized, and 
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poured into sterile petri dishes. The dishes were then 
placed in an anaerobic vacuum jar that was flushed with Ng 
gas and then evacuated under vacuum several times. After 
drying overnight, the plates were inoculated, placed back 
into the jar that was made anaerobic as was described for 
drying the plates, and incubated at 37°C. This medium was 
also prepared anaerobically as described for SBM; after it 
was boiled and cooled, it was dispensed (8 ml per tube) to 18 
X 142 mm roll tubes that contained 0.12 g agar (Difco) as 
described by Holdeman et al. (1977). After sterilization, 
roll tubes were fashioned. 
CBA supplemented with 0.5% sodium pyruvate was also used 
in a method that included an Oxyrase overlay technique. 
Sodium lactate (60% syrup), 4.7 ml, and agar, 20 g, were 
added to 1 liter of 20 mM sodium phosphate buffer, pH 7.5. 
The mixture was heated in a microwave oven and dispensed 15 
ml per tube to screw-capped tubes. The tubes were sterilized 
in an autoclave (121°C for 15 min), and cooled to 45°C. To 
each tube, 0.15 ml of Oxyrase was aseptically added, and the 
molten Oxyrase solution was poured over an inoculated CBA 
plate. The plates were then incubated (in air) at 37°C. The 
Oxyrase overlay was also prepared with the addition of 1 mg 
per ml cycloheximide, 1.6 /xg per ml clindamycin, and 3 /ig per 
ml erythromycin. The cycloheximide was added after boiling 
but before sterilization. The tubes were sterilized in an 
autoclave for 12 min at 121°C. Clindamycin and erythromycin 
were added as filter-sterilized (0.22 nm pore size) solutions 
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after the overlay was sterilized. 
Modified lecithin/cholesterol Tween 80 roll tubes (MLT) 
contained per liter: lecithin (Sigma, type II-S), 0.3 g; 
cholesterol, 0.2 g; casitone, 16 g; yeast extract, 5 g; NaCl, 
2.5 g; L-cystine, 0.25 g; sodium thioglycolate, 1 g; KHgPO^, 
1.2 g; KgHPO^, 3.8 g; resazurin, 1 mg; sodium pyruvate, 0.5 
g; and Tween 80, 0.2 ml. This medium was prepared 
anaerobically and dispensed, 8 ml per tube, to roll tubes (25 
X 140 mm) containing 0.13 g of agar. Tubes were sterilized 
in an autoclave (121°C for 15 min). MLT was also made with 
0.5% phenethyl alcohol and with twice the normal 
concentration of agar (MLTP) to inhibit swarming bacteria. 
This medium was also prepared with the omission of Tween 80, 
and the addition of 0.1% (w/v) of deoxycholic acid (Sigma). 
BM was prepared as previously described and dispensed 
(10 ml per tube) to 25 x 140 mm roll tubes that contained 
0.15 g agar, sterilized, and cooled at an angle to form agar 
slants. BC agar (BCA) contained the following components per 
liter: lecithin (type IV-S, Sigma), 10 g; cholesterol, 20 g; 
casitone, 10 g; yeast extract, 10 g; trypan blue (Allied 
Chemical Co., NY), 100 mg; BiTek agar (Difco), 17.5 g; and 
CaCl2'2H20, 1 g. The lecithin and cholesterol were 
homogenized with dHgO in a Waring blender for 10 min under a 
stream of gas, the other components were added, the pH was 
adjusted to 7.2, and the medium was sterilized in an 
autoclave. Flasks containing 500 ml of medium were 
sterilized for 45 min at 121°C. After sterilization, the 
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medium was stirred as it cooled to 45°C; then, it was poured 
into petri dishes and dried overnight in a vacuum desiccator. 
The plates were then inoculated and incubated in a GasPak jar 
containing a GasPak Plus anaerobic system envelope with 
palladium catalyst (Becton Dickinson Microbiology Systems, 
Cockeysville, MD) with a layer of silica gel desiccant in the 
bottom of the jar and incubated at 37°C. This medium was 
also prepared with the substitution of 0.7% Gelrite 
(Schweizerhall, South Plainfield, NJ) for agar (BCG). In 
addition, EGA and BCG media were prepared as prereduced media 
and used in a Wolfe bottle method (Hermann et al., 1986). 
À modification of the lecithin agar (MLA) used by 
Chrisope et al. (1976) was used for the isolation of CRB. 
MLA medium was prepared as described for lecithin agar, 
except fraction A contained lecithin, 3 g; cholesterol, 6 g; 
and dHgO, 135 ml, and was homogenized in a Waring blender for 
10 min. Fraction B contained casitone, 3 g; yeast extract, 3 
g; BiTec agar (Difco), 5.4 g; trypan blue, 30 mg; and dHgO, 
150 ml. The pH of fraction B was adjusted to 7.2. Fraction 
C contained GaClg'ZHgO, 0.3 g, dissolved in 15 ml dHgO. 
These 3 fractions were sterilized in an autoclave (121°C for 
20 min) in separate containers and then tempered to 45°C in a 
water bath. The fractions were then carefully combined with 
gentle swirling in the order A + (B + C), then poured into 
sterile petri plates. The agar plates were dried overnight 
at room temperature under vacuum in a desiccator that 
contained CaClg pellets. After inoculation, the plates were 
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placed in a GasPak jar containing a GasPak Plus anaerobic 
system envelope with palladium catalyst and incubated at 
37°C. 
Growth of cholesterol-reducing bacteria in clear media 
Pure cultures of CRB were grown in cholesterol- or 
brain-containing media. They were then transferred to one of 
the clear cholesterol-containing media and incubated at 37°C 
for 1 week. The cultures were transferred weekly in the 
clear media for 5 weeks. After the fifth transfer, the 
cultures were inoculated into a brain-containing medium, 
incubated for 1 wk, and extracted. The extracts were assayed 
for coprostanol. 
Isolation procedure 
Samples were collected in 25 x 140 mm tubes, sealed with 
butyl rubber stoppers, and immediately transported to the 
laboratory where they were diluted and inoculated into 
various media. Cultures were incubated at 37°C for 7 to 21 
d, then extracted and assayed for coprostanol. The highest 
dilution that tested positive for coprostanol was again 
serially diluted, incubated, and assayed. This was repeated 
several times to reduce background bacteria. 
Anaerobic digestor and raw sewage samples were collected 
from a municipal waste treatment plant. Samples were also 
collected from freshly voided feces of a baby goat and from 
an adult goat. The adult goat had been fed a high-
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cholesterol (2% w/w) diet. The samples were serially diluted 
in VPI anaerobic diluent (Holdeman et al., 1977) to 10~^°, 
then inoculated into medium IC, BHI-SOC broth, BHI-S broth, 
SPBO broth, MRS-OC broth, and LBS-OC roll tubes. The samples 
were also serially diluted in sterile 0.1% peptone blanks and 
inoculated into AC-OC broth. In addition, dilutions of adult 
goat feces were inoculated into TMB broth, BHI-SOC broth, and 
modified MIO broth. Rumen fluid from the adult goat was 
serially diluted in VPI diluent and inoculated into SPB 
broth, modified MIO broth, and BHI-SOC broth. 
Freshly voided horse feces were collected, diluted, and 
inoculated into LIP medium, BHI-SOC broth, TMB broth, and 
SPPL broth. Samples from human and cat feces were serially 
diluted in TMB broth containing sodium pyruvate and CuSO^. 
The following samples were diluted and incubated in BM 
broth; sponge from a salt water aquarium, sediment samples 
from rivers, streams, and ponds in the Ames, lA area, and 
samples of commercially packaged, frozen pork brains. 
Samples from soil, cattle and sheep confinement-area 
runoff, hog sewage lagoon, rotting hay, wet tree leaves, 
sediment from ponds, streams, and drainage ditches, standing 
water, rotting wood, and wet grass were collected. These 
samples were diluted in TC medium and incubated at 37°C for 1 
week. 
The highest coprostanol-producing dilutions were again 
serially diluted in the same medium in which they were 
originally inoculated or in BC broth. After this was 
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repeated several times, the cultures were transferred weekly. 
Samples that coagulated the cholesterol-containing media 
and that tested positive for coprostanol were inoculated onto 
various plating media for isolation of cholesterol-reducing 
bacteria. Isolated colonies of every morphological type 
evident were picked with a sterile platinum needle and 
inoculated into SBM, SPB, TMB, BM, or BC broths. These 
cultures were incubated for 7 to 21 days (37°C) and then 
tested for coprostanol production. Coprostanol-positive 
cultures were Gram-stained (Holdeman et al., 1977) and 
restreaked to a solid plating medium. 
Sterol conversion assay 
Samples that originated from sources expected to contain 
cholesterol esters were first saponified. Samples (2 ml) 
were placed in 18 X 150 mm screw-capped tubes. Ethanol 
(95%), 6 ml, and KOH (33%), 6 ml, were added, and the tubes 
mixed on a vortex mixer. They were then placed in a water 
bath at 55°C for 30 min. After cooling, 10 ml of hexane was 
added to each tube, and the tubes were vigorously mixed. 
Distilled water (4 ml) was added, the tubes were mixed again, 
and then the tubes were subjected to centrifugation for 10 
min at 1000 X G to separate the phases. The top (hexane) 
layer was removed to a vial and evaporated under air at room 
temperature. The lipids were resuspended in 2 ml of 
chloroform. Samples that were not expected to contain 
cholesterol esters were simply extracted with hexane as 
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above. 
Samples were spotted on silica gel thin-layer 
chromatography (TLC) plates (Si250-PA, J. T. Baker, Inc., 
Phillipsburg, NJ). The plates were developed in hexane-ethyl 
acetate (80:20). Sterol spots were visualized by overnight 
exposure to iodine vapors in a sealed container. Permanent 
records of TLC plates were made by placing the developed 
plates on a clear glass plate that was positioned on a 
photoduplication machine. 
Results and Discussion 
Media development 
Brain-containing media (SBM and TMB) were difficult to 
prepare using Hungate techniques (Holdeman et al., 1977) 
because the homogenized media foamed excessively during 
boiling. However, if caution was exercised and a large 
headspace was allowed in the boiling flask, the medium could 
be prepared. The three strains of cholesterol-reducing 
eubacteria all grew in the brain-containing media. The media 
coagulated after 3 to 5 days of incubation. When samples 
were saponified, extracted, and assayed by TLC, approximately 
50 to 90% of the cholesterol had been converted to 
coprostanol. 
To facilitate the isolation of cholesterol reductase, 
attempts were made to grow the eubacteria in a clear medium. 
No colonies were evident when the eubacteria were streaked to 
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solidified roll tubes of WSRT agar. Eubacteria grown in SBM 
or TMB media were inoculated (10% inoculum) into the 
following media: LIP, SPPL, T-LIP, AGO, CDBM, SOT, and XLP. 
The cultures were incubated for 1 week and then transferred 
(1% inoculum) into fresh media. This was repeated 5 times; 
then, the cultures in each type of medium were assayed for 
coprostanol production and inoculated into a brain-containing 
medium. After 5 transfers, there was no obvious turbidity in 
any of the clear media, the cultures were negative for 
coprostanol production, and no subsequent growth or 
coprostanol production was observed after inoculation into 
SBM or TMB media. No growth was evident when CRB were 
inoculated and transferred in BHI-S, modified MIO, PY, or PYG 
media. 
The water-soluble cholesterol preparation (Sigma) may 
have been toxic to the eubacteria, or may be in a form that 
is not utilizable by the bacteria. This may be why no growth 
was observed on WSRT or SPPL media. According to Eyssen et 
al. (1973), their cholesterol-reducing eubacterium required 
at least 1 to 2 mg of cholesterol per ml of growth medium. 
LIP medium contained a high concentration of cholesterol (7.6 
mg per ml) that remained dissolved in the medium. It also 
contained Folch Brain Extract that would be expected to 
contain plasmenylethanolamine. The lack of growth in this 
medium may be explained by the presence of cholic acid in 
toxic amounts, or the cholesterol may not have been in a form 
that was accessible to the bacteria. T-LIP, AGO, and CDBM 
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media each contained 2 mg per ml of cholesterol and no cholic 
acid, but did not contain plasmenylethanolamine. Mott and 
Brinkley (1979) determined that the CRB that they studied 
required plasmalogen to grow and reduce cholesterol. It was 
hoped that a different form of cholesterol would negate the 
requirement for plasmalogen, or that the eubacteria could be 
gradually "weaned" from this requirement. Unfortunately, 
this was not successful. Media that contained serum or 
Ex-Cyte I also did not support the growth of the three 
strains of CRB tested. The reason may have been the lack of 
plasmalogen, or the Eh of the medium may not have been 
sufficiently low. XLP medium did support the growth of a new 
cholesterol-reducing isolate, Eubacterium sp. strain HL. The 
isolation and characterization of two isolates, one of which 
was studied in detail, will be discussed further in Part II 
of this dissertation. 
When pure cultures of CRB were grown in TMB medium 
supplemented with riboflavin, L-lysine, or L-arginine, 
coprostanol production was not appreciably increased. 
Coprostanol production was greater in TMB that contained 
sodium thioglycolate as the reducing agent than in TMB 
containing cysteine. Coprostanol was also produced more 
efficiently in TMB medium when potassium phosphate was 
deleted from the formulation, than when the medium contained 
potassium phosphate. 
Cholesterol conversion by stable mixed cultures of CRB 
in BM was not stimulated by sodium pyruvate, sodium formate. 
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sodium selenite, Tween 80, glycyrrhizin, pNPG, hemin, or 
vitamin K^. The intensity of the TLC spot corresponding to 
coprostanol increased with increasing concentrations of 
CaClg up to 1 mg per ml. At concentrations of CaClg greater 
than 1 mg per ml, coprostanol production was inhibited. 
Mixed cultures of CRB were capable of converting 
stigmasterol, ergosterol, and 4-cholesten-3-one to their 
corresponding 3-8-hydroxyl, 5-6 derivatives. Androstenedione 
was not reduced. 
Preliminary studies on the isolation of cholesterol-reducing 
bacteria and on cholesterol reductase 
In an attempt to isolate cholesterol-reducing bacteria 
with unique properties, several sources were sampled that had 
not previously been investigated. An anaerobic sewage 
digestor was sampled. The environment within the digester 
was very anaerobic, and cholesterol and related plant sterols 
were present. Samples from the digestor did contain 
coprostanol, but no stable mixed cultures or pure cultures of 
CRB were obtained from this source. Raw sewage was sampled 
because CRB from a diversity of sources may have been 
present, and bacteria capable of tolerating limited amounts 
of oxygen would have survived in this type of environment. 
Aerotolerance would be a desirable characteristic of a CRB to 
be used either experimentally or on an industrial scale. 
Unfortunately, no aerobic, aerotolerant, or anaerobic CRB 
were isolated from this source. 
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It was proven that coprostanol that is produced in the 
rumens of sheep was of bacterial origin (Ashes et al., 1978). 
However, no attempt was made by those workers to isolate the 
CRB. For this reason, the ruminai contents of goats were 
sampled and inoculated into several types of media. 
Coprostanol was evident after 2 transfers but was not 
produced in subsequent transfers. 
An adult goat was fed a high-cholesterol diet in the 
hopes of enriching the relative numbers of cholesterol-
reducing bacteria in vivo. It was observed that the amount 
of coprostanol excreted in the feces did greatly increase, 
although the ratio of coprostanol to cholesterol probably 
remained the same. A mixed culture was obtained from the 
feces of this animal. When the culture was repeatedly 
transferred in cholesterol-containing media, it continued to 
produce coprostanol. 
Horse feces were sampled because horses have an 
extensive large intestine that would be expected to be a rich 
environment for CRB. Several stable mixed cultures were 
obtained that contained CRB from horse feces. Samples that 
were inoculated into BHI-SOC and TMB media were positive for 
coprostanol by TLC assay after 10 to 15 transfers. The CRB 
were apparently resistant to the concentration of Oxgall used 
in BHI-SOC medium. However, after numerous transfers and 
serial dilutions, several distinct morphologies were present 
in Gram stains, and a pure culture could not be obtained. 
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Stable mixed cultures were also obtained from samples of 
human and cattle feces, a marine sponge, sediments from 
rivers, streams, and ponds, standing water, a hog sewage 
lagoon, and commercial frozen pork brains. Many stable, 
mixed cultures were obtained after dilution in TC medium, 
which was not a prereduced medium. This method was used in 
attempts to isolate bacteria that were not strict anaerobes. 
The mixed culture from the marine sponge produced nearly 100% 
coprostanone from cholesterol, and only very faint 
coprostanol bands were evident on TLC plates. Nearly all of 
the stable mixed cultures of CRB produced 4-cholesten-3-one 
and coprostanone in addition to coprostanol. 
Samples from several sources were inoculated into an 
anaerobic medium (IC) that contained cholesterol as a sole 
carbon source. After several transfers in this medium, 
growth was not evident, and samples that were assayed by TLC 
were negative for coprostanol. Unlike bacteria that oxidize 
cholesterol, CRB probably do not break the ring structures of 
cholesterol and cannot assimilate the carbon that exists in 
the cholesterol molecule. 
Stable mixed cultures of CRB were inoculated onto 
various types of solidified media to attempt to isolate pure 
cultures of CRB. Hundreds of trials were conducted. When 
roll-tube techniques were used, isolated colonies could not 
be obtained because the entire surface of the medium became 
covered with bacterial growth, probably from swarming 
bacteria. The addition of phenethyl alcohol and doubling the 
71 
agar concentration did not rectify the problem. Cholesterol-
containing roll tubes were also not clear, so visualizing 
colonies was difficult. CRB on BM agar slants and on agar-
or Gelrite-solidified media in Wolfe bottles also were 
rapidly overgrown by background bacteria. Because the CRB 
that had been isolated previously were relatively slow-
growing bacteria, the solidified media were incubated for at 
least one week. When Oxyrase overlays were made on CBA 
plates, many plates became contaminated. When various 
antibiotics were added to the overlay, the contamination 
problem was solved, but none of the isolated colonies that 
were picked and inoculated to cholesterol-containing media 
produced coprostanol. Although approximately 1000 colonies 
were picked, grown in cholesterol-containing media, extracted 
and assayed by TLC, no CRB were isolated using any roll tube, 
agar slant, Wolfe bottle, or Oxyrase overlay technique. 
In an attempt to selectively enrich for CRB, several 
selective agents were incorporated into various media. 
Stable mixed cultures of CRB continued to grow and reduce 
cholesterol in the following media: BHI-SOC, SPBO, TMB with 
phenethyl alcohol, and TMB with clindamycin and erythromycin. 
Cultures also grew in BM medium plus phenethyl alcohol and in 
media containing deoxycholic acid, and CuSO^. Samples that 
were inoculated into media selective for lactobacilli tested 
negative for coprostanol production after incubation. 
Because of the difficulties encountered in trying to 
obtain pure cultures of CRB, attempts were made to purify 
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cholesterol reductase from mixed cultures. Various mixed 
cultures were grown in large volumes in several different 
types of growth media. The cells were harvested by 
centrifugation, and washed in buffer. Buffers were used that 
varied in pH, reducing agents, molarity, and degree of 
anaerobiosis. Cells were broken by several techniques, 
including sonication, French press, enzymatic lysis, 
agitation with glass beads, and treatment with detergents and 
organic solvents. Broken cells were treated with and without 
the addition of various protease inhibitors, including 
Pepstatin A, Aprotinin, Leupeptin, and phenylmethylsulfonyl 
flouride (all from Sigma). Cell-free extracts were assayed 
using cholesterol solubilized by several methods as the 
substrate. Reactions were carried out under H^, , COg, Ar, 
or air. Cofactors, including FAD, NAD, NADH, NADP, and 
NADPH, were added alone and in combinations. No cholesterol 
reductase activity was observed in a cell-free fraction using 
any of the techniques listed above. 
Successful isolation of pure cultures of CRB 
A stable mixed culture containing CRB that originated 
from a hog sewage lagoon was diluted in BC medium and spread 
to BCA plates that were incubated at 37°C in a GasPak jar. 
After 5 d of incubation, colonies were picked and inoculated 
into BC broth. The use of pre-dried plates and a layer of 
silica gel dessicant in the GasPak jar eliminated overgrowth 
of the plate by swarming bacteria. After 1 wk of incubation. 
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several of the BC broth tubes had coagulated (Figure 1). 
When these cultures were assayed by TLC, approximately 80% of 
the cholesterol had been converted to coprostanol. A Gram 
stain of the cultures revealed the presence of a single 
morphological type of cells that appeared as small, 
Gram-positive rods. When these cultures were restreaked to 
BCA or MLA plates, a single morphological type of colony grew 
on the plates (Figure 2). The colonies were small 
(approximately 1 mm), and appeared bright white and fibrous 
against the dark blue background of the trypan 
blue-containing agar. Growth was similar on BCA and MLA 
plates, but MLA plates had a smoother, more homogeneous 
surface, making it easier to differentiate the small colonies 
from particles of lipid. Using the same methods, a pure 
culture of a CRB originating from standing water was 
isolated. Both CRB strains had similar cellular and colonial 
morphologies, and efficiently converted cholesterol to 
coprostanol in BC medium. 
• The same method that was used to isolate the two new 
strains of CRB described in the previous paragraph was 
repeatedly tried using the other stable mixed cultures. 
However, no colonies resembling the colonies formed by the 
CRB were observed when the other stable mixed cultures were 
plated. It is likely that the CRB in these cultures had a 
growth requirement for plasmalogen, as was observed for other 
CRB (Mott and Brinkley, 1979). The requirement for 
plasmalogen may have been furnished by other anaerobic 
Figure 1. Photograph of BC medium. Left: tube inoculated 
with strain HL and incubated for 5 d at 37°C. 
Right: uninoculated tube 

Figure 2. Colonies of strain HL on an MLA agar plate after 
incubation for 3 d at 37°C in a GasPak jar 
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bacteria in the mixed culture. It has been reported that 
Bacteroides succinogenes uses isobutyric and valeric acids as 
precursors for the synthesis of long-chain fatty acids and 
fatty aldehydes. These compounds are then used to synthesize 
ethanolamine plasmalogen (Wegner and Foster, 1963). The 
pathway for the formation of plasmenylethanolamine in 
Clostridium butyricum has been elucidated (MacDonald and 
Goldfine, 1990). Cells of CRB that were physically 
disassociated from plasmalogen-producing bacteria on the agar 
plates may not have grown because of the lack of available 
plasmalogen. 
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PART II. CHARACTERIZATION OF A CHOLESTEROL-REDUCING 
BACTERIUM 
Introduction 
Previously isolated strains of cholesterol-reducing 
bacteria (CRB) have been characterized as strains of 
Eubacterium sp. (Eyssen et al., 1973; Sadzikowski et al., 
1977; Mott and Brinkley, 1979; Brinkley et al., 1982). All 
of these strains had been isolated from the fecal contents of 
rats, humans, or baboons, and most had very similar 
characteristics. Because these bacteria had characteristics 
that made them difficult to work with in the laboratory, new 
methods and sample sources were explored for the isolation of 
novel CRB. The isolation of these new strains was described 
in Part I of this dissertation. 
The ability to tolerate limited amounts of oxygen would 
be a valuable attribute of a CRB, because many laboratory 
procedures would be facilitated. Anaerobic bacteria are 
probably sensitive to oxygen because they lack protective 
enzymes and are suseptible to attack by superoxide radicals, 
HgOg, oxidized thiols, and peroxided lipids. These cause 
irreversible damage to the DNA and other cellular components, 
or excessive NADH oxidation that limits the bacterium's 
reducing power (Brusa et al., 1989). When 30 strains of 
freshly isolated intestinal anaerobic bacteria belonging to 
the genera Eubacterium, Peptostreptococcus, and Coprococcus 
were tested, they were all killed within 100 to 120 min 
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(Brusa et al., 1989). Three species of anaerobic intestinal 
bacteria were compared; a great variation existed in oxygen 
sensitivity. After 2 h of aeration, no viable cells of 
Peptococcus magnus were detected. Bacteroides fragilis 
survived aeration up to 5 h, and Clostridium perfringens 
survived up to 10 h (Maiden and Hentges, 1975). Although no 
data have been published as to the aerotolerance of 
previously isolated CRB, all the manipulations used to 
isolate and grow the bacteria were done by using techniques 
designed for cultivating strict anaerobes. 
Another property of previously isolated CRB that made 
them recalcitrant to common laboratory procedures was their 
requirement for a plasmalogen for growth and cholesterol 
reduction (Mott and Brinkley, 1979). Plasmenylethanolamine 
is expensive to sythesize and is not commercially available. 
It is found in high concentrations in mammalian brain tissue, 
so most CRB were grown in brain-containing media. These 
media were very turbid, were not homogeneous, and were 
difficult to make anaerobic. Besides containing cholesterol 
and plasmalogen, brain tissue also contains many other 
components, making biochemical characterization of bacteria 
difficult when using these media. It is impossible to 
harvest cells of CRB from brain-containing media for 
enzymatic assays because a thick, viscous pellet is formed, 
and the brain tissue cannot be separated from the cells. 
The isolation and characterization of unique CRB is also 
important because many questions remain to be answered about 
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their ecological roles in the rumen and intestines of 
animals. Many questions also remain about the physiology of 
these bacteria. Isolation of strains of CRB with unique 
properties may help answer some of these questions. 
Materials and Methods 
Bacteria 
A new strain of CRB, designated Eubacterium sp. strain 
HL, was isolated, as described in Part I. The bacterium was 
maintained by weekly transfer in BC medium (see Materials and 
Methods, Part I), and incubating at 37°C. 
Strain HL, and another unidentified pure culture of a 
CRB, were frozen for long-term preservation. A modification 
of the procedure developed by Teather (1982) was used. B 
medium was prepared as described in Part I, except that the 
concentration of sodium thioglycolate was doubled and a 
volume of glycerol equal to the volume of dHgO was added 
before boiling. The B plus glycerol medium was dispensed, 
1.5 ml per tube, to 13-mm diameter test tubes, and the tubes 
were sealed with butyl rubber stoppers. An overnight 
culture of the bacterium to be preserved, grown in BC medium, 
was aseptically and anaerobically dispensed (2 ml per tube) 
to the sterile, anaerobic B plus glycerol tubes. The 
cultures were briefly mixed by vortexing, and the junction of 
the test tube and the stopper was wrapped with parafilm. The 
tubes were frozen at -20°C. According to Teather (1982), 
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bacteria stored in this manner can be repeatedly thawed, 
sampled, and refrozen without significant loss of viablility 
and can be stored for at least 2 years. 
Media 
The basal medium used in the biochemical 
characterization was similar to the medium used by Brinkley 
et al. (1982) and contained the following components per 
liter: Casitone (Difco), 10 g; yeast extract, 10 g; lecithin 
(type IV-S; Sigma), 1 g; sodium thioglycolate, 0.5 g; 
cholesterol, 2 g; KjHPO^, 40 mg; KHgPO^, 40 mg; CaCl2*2H20, 1 
g; and resazurin, 1 mg. The cholesterol and lecithin were 
homogenized with 300 ml of distilled water (dHgO) in a Waring 
blender for 5 min at high speed under a stream of Og-free Ar. 
The homogenized lipids were added to the remaining components 
dissolved in 700 ml of dH^O. The pH was adjusted to 7.2. 
The medium was reduced by using the Hungate technique 
(Holdeman et al., 1977). The medium was boiled for 5 min 
under a stream of Ar that had been purified of contaminating 
Og by passage over hot, reduced copper. After cooling to 
below room temperature (with swirling to keep the lipids 
dispersed), the medium was dispensed (4 ml per tube) to 13-mm 
diameter tubes. The tubes were sealed with butyl rubber 
stoppers, placed in an anaerobic press, and sterilized in an 
autoclave for 15 min at 121"C. The tubes were inverted 
several times while cooling to keep the lipids dispersed. 
Brain heart infusion agar (Difco) was prepared with the 
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addition of 0.5% sodium pyruvate, 1% lecithin, and resazurin 
(1 mg per liter). Rogosa SL broth (Difco) was prepared 
according to the manufacturer's instructions, except 0.2% 
cholesterol and 0.1% lecithin were homogenized and added in 
the same manner as used for the preparation of BC medium. 
For the determination of nitrate reduction, a medium was 
formulated that contained the following components per liter; 
Beef extract (Difco), 3 g; peptone (Difco), 5 g; KNO^, 1 g; 
lecithin (type IV-S; Sigma), 1 g; and cholesterol, 2 g. The 
lecithin and cholesterol were homogenized, and the medium was 
prepared in the same manner as the basal medium described 
above, exept it was dispensed to 16-mm diameter tubes (9 ml 
per tube). To test for growth, samples of nitrate reduction 
medium that had been inoculated with strain HL and incubated 
for 3 d at 37°C were extracted, and the sterols were 
separated by thin-layer chromatography (TLC) as described in 
Part I. 
Characterization of strain HL 
To determine the optimal medium for the production of 
cholesterol reductase, several formulations were compared. 
BC medium was prepared as described in Part I. BC medium was 
also prepared but with one-tenth the normal concentrations of 
lecithin, cholesterol, and CaClg (BC.l medium). BC.l medium 
was also prepared with 0 mM, 10 mM, and 25 mM PIPES buffer 
(Sigma), pH 7.0. After the media were sterilized and cooled, 
filter-sterilized solutions of sodium pyruvate and lactose 
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that had been bubbled with Ar for 30 min were added, alone 
and in combination, to BC.l media containing the three 
concentrations of PIPES. The final concentrations of sodium 
pyruvate were 0, 0.02, and 0.5%. The final concentrations of 
lactose were 0, 0.5, and 1.0%. BC.l medium with no buffer, 
0.5% sodium pyruvate, and 0.5% lactose was designated SGM 
medium. 
The optimal medium for the production of cholesterol 
reductase was determined by incubating resting cells of 
strain HL grown in various media, with a reaction mixture 
that contained radiolabeled cholesterol. Strain HL was grown 
in BC medium and BC.l medium containing various combinations 
and concentrations of PIPES, lactose, and sodium pyruvate for 
2 days. The bacterium was harvested by centrifugation at 
10000 X g at 4°C for 30 min. The pellet was resuspended in a 
volume of buffer (50inM PIPES, 0.5% sodium thioglycolate, pH 
7.0) corresponding to 10% of the original growth medium. 
Samples (1 ml) of the cell suspension were incubated for 1 h 
at 37"C with 160 /il of radiolabeled cholesterol substrate. 
The substrate consisted of a sonicated suspension of 
phosphatidylcholine, 10 mM; cholesterol, 7.5 mM; 
[la,2a(n)-^H]cholesterol (specific activity 44.3 Curies per 
mmole; Amersham Corp., Arlington Heights, IL), 20 /il; and 
buffer, 20 ml. After incubation, the reaction mixture was 
extracted with chloroform-methanol (2:1; v;v). Sterols were 
separated by TLC, using silica gel-H plates (0.75 mm 
thickness). The plates were developed in hexane-ethyl 
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acetate (75:25). Sterol spots were visualized by using a 
0.2% ethanolic solution of 2,7-dichlorofluorescein. Spots 
corresponding to authentic cholesterol and coprostanol 
standards (Steraloids Inc., Wilton, NH) were scraped from the 
plates, and radioactivity was determined by using a Beckman 
LS-8000 liquid scintillation spectrophotometer (Beckman 
Instruments Inc., Palo Alto, CA). Net counts per minute 
(CPM) are reported as the average total CPM of duplicate or 
triplicate samples minus the average total CPM of the 
corresponding reaction mixture that contained bacteria that 
had been boiled for 10 min. 
Several parameters of the resting-cell assay were 
optimized. Strain HL was transferred to fresh BC medium (10% 
inoculum) and incubated overnight. This culture was used to 
inoculate SGM medium (1% inoculum). To ascertain the best 
time to harvest strain HL for enzymatic assays, the SGM 
culture was incubated, and samples were removed at various 
time intervals for use in the resting-cell assay. In another 
experiment, a 48-h culture of HL in SGM medium was used in 
the resting-cell assay. Cells were incubated with the 
reaction mixture for periods of 1, 2, and 3 h. The effects 
of pyruvate in the growth medium were determined by 
inoculating strain HL into SGM medium containing various 
concentrations of pyruvate (0 to 2%) and assaying the resting 
cells. Cells were also grown in SGM medium without pyruvate, 
and then incubated in resting-cell reaction mixtures that 
contained from 0 to 1% sodium pyruvate. 
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Strain HL was inoculated into SGM medium containing from 
0 to 1% yeast extract. After 3 transfers (1% inoculum), the 
cells in overnight cultures were enumerated by a direct count 
method (Packard and Ginn, 1985). Because of problems in 
counting caused by clumping in SGM medium, 1-ml samples of 
culture were added to 1 ml of a 10% solution of Tween 80 in 
dHgO. Samples (10 /il) of each culture were then placed on a 
microscope slide, dried, heat fixed, stained with crystal 
violet solution for 2 min, rinsed with dHgO, dried, and 
counted. Cultures of strain HL grown in regular SGM and in 
SGM without yeast extract were diluted and spread to plates 
of MLA (described in Part I) to determine colony forming 
units (CPU). The CPU of strain HL after 4 transfers in 
Rogosa SL broth, BC medium, SGM, and BC plus 10 mM MES, pH 
5.5, were also determined by using MLA plates. 
To assay for growth and coprostanol production at 
various pH values, BC was prepared without buffer, and the pH 
was adjusted with HCl or KOH to values ranging from 5.5 to 
8.0. An overnight culture of strain HL in BC medium was 
inoculated (1% inoculum) into the media. After incubation 
for 18 h at 37°C, the media were extracted, and the extracts 
were assayed by TLC. BC was also prepared in each of the 
following buffers (50 mM): acetate, pH 5.0; citrate-
phosphate, pH 5.6; phosphate, pH 6.4 and pH 7.2; Tris-HCl, pH 
7.6; and Tris-HCl, pH 8.0. In addition, BC was formulated 
with the following buffers (10 mM; Sigma): MES, pH 5.5; 
PIPES, pH 7.0; and EPPS, pH 8.0. 
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To test for the ability of strain HL to grow in the 
absence of added cholesterol, BC medium was prepared without 
cholesterol (BLEC medium). Strain HL grown in BC medium was 
inoculated into BLEC medium and serially diluted. After 1 wk 
of incubation at 37°C, the highest dilution that had a grainy 
appearance was transferred to fresh BLEC medium. Strain HL 
was transferred 10 times in BLEC medium to confirm growth 
without cholesterol. This culture was then inoculated into 
BC medium, incubated 3 d, and assayed for coprostanol 
production by TLC. 
For the determination of phospholipase activity, samples 
of strain HL grown in BLEC medium (2 ml) were extracted with 
3 ml of chloroform-methanol (1:1). For phosphatidyl choline 
determination, TLC plates (Si250-PA; J. T. Baker Inc., 
Phillipsburg, NJ) were spotted with 10 or 20 fxl samples, and 
developed with chloroform-methanol-glacial acetic acid-water 
(100:56:20:10). For free fatty acid determination, TLC 
plates were developed with hexane-ethanol-acetic acid 
(80:20:1). Lipid spots were visualized with iodine vapors 
after overnight exposure in a sealed container. 
The ability of strain HL to grow in a cholesterol- and 
lecithin-free medium was determined by inoculating the 
bacterium into a lipid-free medium and observing turbidity 
after several transfers. Cultures were transferred every 3 d 
for a total of 5 times; then, these cultures (1% inoculum) 
were inoculated into BC broth. After 1 wk of incubation, the 
BC broth cultures were observed for coagulation and assayed 
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by TLC. The media tested included BC broth without 
cholesterol or lecithin (B medium), and B medium plus one of 
the following; 0.8% glycerol, 1.0% lactose, 0.02 or 0.5% 
sodium pyruvate, 0.05% sodium oleate and 0.02% sodium 
pyruvate, or VPI hemin and vitamin solutions (Holdeman et 
al., 1977). In a similar manner, the growth of strain HL in 
a clear, cholesterol-containing medium (XLP medium, prepared 
as described in Part I) and in B medium plus 0.2 mg per ml of 
5-androstene-3B-ol-176-carboxylic acid (Sigma) was tested. 
The efficiency of coprostanol production by strain HL 
was determined by comparing the intensity of the coprostanol 
spots on TLC plates after growing the bacterium in various 
media. BC medium was prepared with the addition of one of 
the following: formate/fumarate solution (Holdeman et al., 
1977), 0.5% amygdalin, 1 mM dithiothreitol, 1.0% glucose, 
0.75% lactic acid, 1.0% lactose, 0.5% sodium acetate, or 0.5% 
sodium pyruvate. BC medium was also prepared with the 
substitution of an equimolar concentration of MgClg'GHgO for 
CaCl2*2H20. To determine growth and cholesterol reduction at 
various temperatures, tubes of BC medium were inoculated (1%) 
with strain HL, incubated at room temperature (about 25°C), 
30, 37, 45, and 55°C, and then assayed by TLC. 
To investigate the growth and cholesterol-reducing 
capabilities of strain HL in media containing various 
phospholipids, BC medium with 0.02% sodium pyruvate was 
prepared as described above, except without cholesterol, 
lecithin, or CaClg (BP medium), and dispensed to 13-mm 
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diameter tubes (4.5 ml per tube). The following 
phospholipids were dissolved separately (45 mg each) in 5 ml 
of 95% ethanol at 60°C that contained 90 mg of cholesterol: 
phosphatidyl inositol (Sigma; approximately 50% pure), 
phosphatidyl choline (Sigma; approximately 40% pure), 
phosphatidyl choline (Calbiochem, Behring Diagnostics, La 
Jolla, CA; 97% pure), and phosphatidyl glycerol (Sigma; 98% 
pure). Cholesterol (90 mg) was also dissolved alone in 5 ml 
of ethanol. The ethanolic solutions were sterilized by 
passage through 0.22-pm pore size syringe filters. A 2-d 
culture of strain HL grown in BLEC medium was serially 
diluted to lo"^ in replicate tubes of BP medium. Each 
phospholipid/cholesterol solution and the cholesterol 
solution were added (50 /il per tube) to duplicate tubes of 
the 10~^ dilutions of strain HL. A sterile, anaerobic 
solution of CaCl2*2H20 in dHgO (9%, w/v) was also added (50 
Hi per tube). The cultures were incubated at 37°C for 2 wk, 
then extracted, and assayed by TLC. 
Similar experiments were performed to determine if 
putative intermediates were reduced to coprostanol. 
4-Cholesten-3-one (Sigma, 90 mg) or cholesterol (90 mg) were 
each dissolved with 45 mg of 40% phosphatidyl choline in 5 ml 
of 95% ethanol at 60°C, and added (50 /il) to tubes containing 
4.5 ml of BP medium prepared without pyruvate (B medium). 
Strain HL that had been transferred (1% inoculum) 4 
consecutive times in BLEC medium was inoculated (1%) to tubes 
of B medium containing 4-cholesten-3-one with phosphatidyl 
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choline, or cholesterol with phosphatidyl choline. The tubes 
were incubated 1 wk, extracted, and assayed by TLC. The 
biohydrogenation of coprostanone to coprostanol by strain HL 
3 13 
was also determined. The compound [4- H, 4- C]-coprostanone 
was prepared as previously described (Ren, D., 1991. M.S. 
thesis, Iowa State University, Ames, lA). This substrate was 
added to BC medium that was inoculated with strain HL and 
incubated at 37°C for 3 d. The sterols were extracted twice 
with 2 ml of a chloroform- methanol (2:1) solution. The 
organic phase was concentrated to approximately 100 fil. TLC 
and liquid scintillation counting were performed as described 
for the resting cell assay, except that sterol spots 
corresponding to authentic coprostanone and coprostanol 
standards were scraped into scintillation vials for isotopic 
measurements. 
A similar technique was used to determine the amount of 
cholesterol converted to coprostanol with time. 
[4-^H]-cholesterol (3 /il, in 95% ethanol; 2.6 /iCi) and 
[4-^^C]-cholesterol (3 nl, in 95% ethanol; 2.5 fiCi) were 
added to 9 ml of BC medium that was inoculated with 1 ml of 
an overnight culture of strain HL. Samples were removed each 
day for 7 days, and the amount of radioactivity in 
coprostanol was assayed as described above. 
Strain HL was tested for reduction of nitrate, 
production of indole, hydrolysis of starch, gelatin, and 
esculin, and the fermentation of amygdalin, arabinose, 
cellobiose, erythritol, fructose, glucose, glycogen, 
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inositol, lactate, lactose, maltose, mannitol, mannose, 
melibiose, raffinose, rhamnose, ribose, salicin, soluble 
starch, sucrose, and xylose. Filter-sterilized solutions of 
substrates were added to sterile basal medium to yield the 
final concentrations recommended by Holdeman et al. (1977). 
The test media were inoculated with 0.1 ml of strain HL grown 
in BC medium. The cultures were incubated at 37°C for 7 d, 
at which time the pH of the inoculated media were compared to 
uninoculated controls. The reduction of nitrate, production 
of indole, and the hydrolysis of starch, gelatin, and esculin 
were tested as described in the Anaerobic Laboratory Manual 
(Holdeman et al., 1977). 
For the determination of Hg and COg production, media 
were dispensed (20 ml per tube) to 16 x 150 mm tubes that 
were sealed with rubber septum serum caps. BC, BC plus 0.5% 
lactose, BC plus 0.5% sodium pyruvate, BC plus 0.5% lactose 
and 0.5% sodium pyruvate, and SGM media were inoculated (1% 
inoculum) with strain HL grown in BC medium. Lactose and 
pyruvate were added as filter-sterilized solutions that were 
made partially anaerobic by bubbling with Ar for 10 min. The 
cultures were incubated at 37°C for 7 d. Headspace gas was 
analyzed on a Gow Mac series 580 gas chromatograph 
(Bridgewater, NJ) equipped with a thermal conductivity 
detector and a Hewlett-Packard 3393A integrator (Avondale, 
PA). Samples were removed from the culture tubes with a 
gas-tight syringe and injected into the sample loop (0.5 ml). 
Ng was the carrier gas for Hg determination, and He was the 
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carrier gas for CO^ determination. The Hg and CO g 
concentrations in the headspace of the cultures were compared 
with the concentration in the headspace over uninoculated 
media. 
To determine fermentation products, strain HL was grown 
in BC medium. The BC culture was used to inoculate BC medium 
plus 0.5% sodium pyruvate, BC medium plus 0.5% sodium 
pyruvate and 0.5% lactose, BC medium plus 1.0% glucose, and 
SGM medium. After 4 d of incubation at 37°C, the presence of 
butanol, ethanol, isopropanol, methanol, and propanol were 
determined by injection of culture supernatants into a 
Hewlett-Packard gas chromatograph model 5890 equipped with a 
capillary column (5% phenyl-methyl silicone, 10 m x 0.53 mm x 
2.65 /im film thickness), a 7673A automatic sampler, an HP3396 
Series II integrator, and a hydrogen flame ionization 
detector. The carrier gas was , and the column temperature 
was 40°C. The formation of acetic, butyric, caproic, formic, 
fumaric, isobutyric, isovaleric, lactic, oxalic, 
phenylacetic, propionic, and succinic acids by strain HL were 
determined by using the method for preparing butyl esters 
described by Salanitro and Muirhead (1975). Butylated 
samples were analyzed on the same gas chromatograph system 
described for determining alcohols, except the column 
temperature was increased 8°C per min between 55 and 190 " c .  
In addition to standard biochemical tests, strain HL was 
evaluated by using the An-IDENT system (Analytab Products, 
Plainview, NY). The An-IDENT system contains tests for the 
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following activities: indole production, N-acetyl-
glucosaminidase, a-glucosidase, a-arabinosidase, 
B-glucosidase, a-fucosidase, phosphatase, a-galactosidase, 
13-galactosidase, hydrolysis of indoxyl-acetate, arginine 
utilization, leucine, proline, tyrosine, arginine, alanine, 
histidine, phenylalanine, and glycine aminopeptidases, 
pyroglutamic acid arylamidase, and catalase. A bacterial 
suspension was obtained from 3-d-old cultures grown on MLA 
plates that were incubated in a GasPak jar (described in Part 
I). The procedures outlined by the manufacturer were 
followed. 
Aerotolerance was determined by incubating inoculated 
MLA plates in a GasPak jar for 5 d and then exposing the 
plates to air at room temperature. Isolated colonies were 
picked at various times after exposure to air and were 
inoculated into BC broth. After 1 wk of incubation, the 
cultures were extracted and analyzed by TLC for coprostanol 
production. Strain HL was also inoculated to MLA plates that 
were placed in a candle jar, an evacuated vacuum jar, and in 
air, and incubated at 37°C for 2 wk. The plates were then 
examined for growth. 
Results 
Strain HL grew and converted approximately 90% of the 
radiolabeled cholesterol in BC medium to coprostanol in 5 
days (Figure 1). When strain HL was grown in BC medium for 2 
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Figure 1. Percentage changes in cholesterol and 
coprostanol concentrations as incubation 
proceeded. Strain HL was incubated in BC 
medium containing radiolabeled cholesterol 
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d and the sterol spots visualized on TLC plates, a 
significant amount of the cholesterol had been converted 
(Figure 2, lane 3). 
The results of preliminary studies, using a resting-cell 
assay with radiolabeled cholesterol, indicated that medium 
BC.l yielded higher cholesterol reductase activity than 
medium BC. BC.l medium was further optimized for enzyme 
yield by testing various combinations and concentrations of 
PIPES, lactose, and pyruvate. The highest cholesterol 
reductase activity was obtained in BC.l medium with 0% PIPES, 
0.5% lactose, and 0.5% sodium pyruvate (SGM medium; data not 
shown). 
The results of resting-cell sterol conversion assays are 
shown in Figures 3-6. The highest cholesterol-reducing 
activity by strain HL was evident between 24 and 48 h of 
growth (Figure 3). After up to 3 h of incubation of the 
reaction mixture, cholesterol reductase activity continued to 
increase in a nearly linear manner (Figure 4). The addition 
of pyruvate to the growth medium greatly stimulated 
cholesterol-reductase activity (Figures 2 and 5). Pyruvate 
also stimulated activity when added to the enzyme reaction 
mixture (Figure 6). 
Difficulties were encountered in making direct counts of 
cells of strain HL grown in SGM medium with various 
concentrations of yeast extract because of the small size of 
the bacterium and the presence of particulate constituents of 
•7 
the medium. Counts of approximately 3.4 X 10 cells per 
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Contaminants 
4-Cholesten-3-one 
Coprostanol 
Cholesterol 
Figure 2. TLC of strain HL incubated 2 d in BC medium 
containing various carbohydrates, lactate, or 
pyruvate. Lane 1: amygdalin; Lane 2; glucose; 
Lane 3: normal BC medium; Lane 4: pyruvate; Lane 
5: lactate; Lane 6; standards (10 ng per spot) 
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Figure 3. Net radioactivity of coprostanol as a function 
of the incubation time of Eubacterium HL in 
SGM medium 
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Figure 4. Net radioactivity of coprostanol as a function of 
the time of incubation of the assay reaction 
mixture 
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Figure 5. Net radioactivity of coprostanol as a function of 
the pyruvate concentration of the growth medium 
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Figure 6. Net radioactivity of coprostanol as a function of 
the pyruvate concentration of the assay reaction 
mixture 
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ml were obtained for SGM medium without yeast extract, and 
approximately 4.8 X 10^ cells per ml for SGM medium 
containing 1% yeast extract. Colony counts on MLA plates 
were 2 X 10^ CFU per ml for cultures grown in SGM without 
yeast extract, and 1.8 X 10^ CFU per ml when 1% yeast extract 
was added to the growth medium. After 4 consecutive 
transfers, then 24 h of incubation, CFU per ml on various 
media were: Rogosa SL broth plus cholesterol and lecithin, 
0; BC medium, 3.5 X 10®; SGM, 2.6 X 10^; and BC medium plus 
10 mM MES, pH 5.5, 5.5 X 10®. 
The effects of pH on coprostanol production were tested 
with strain HL. When the bacterium was grown in BC medium 
containing organic or inorganic buffers, the best coprostanol 
production as visualized by TLC assay occurred at about pH 
7.0 (lanes 5,7,9,and 11, Figure 7). The amount of 
coprostanol produced at this pH was approximately the same as 
the amount of coprostanol produced at pH 7.2 in BC medium 
without a buffering system (lane 5, Figure 7). After 48 h, 
there was no coprostanol produced in BC medium buffered to pH 
5.5 with MES (lanes 1 and 2, Figure 7) or to pH 8.0 with EPFS 
(lanes 3 and 4, Figure 7). The results of coprostanol 
production in unbuffered BC medium in which the pH was 
adjusted to various levels are shown in Figure 8. The 
greatest amounts of coprostanol were formed at pH values of 
7.5, 7.2, and 7.0 (lanes 3-5, Figure 8). After incubation, 
the pH values of these media were 6.4, 6.3, and 6.2, 
respectively. 
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Figure 7. TLC of cultures of strain HL incubated in BC 
medium with various additions, sampled at 24 and 
48 h. Lanes 1 and 2: MES, pH 5.5, 24 and 48 h; 
Lanes 3 and 4: EPFS, pH 8, 24 and 48 h; Lane 5: 
no additions, 48 h; Lanes 6 and 7; PIPES, pH 
7.0, 24 and 48 h; Lanes 8 and 9: 0.5% sodium 
acetate, pH 7.0, 24 and 48 h; Lanes 10 and 11: 
PIPES, pH 7.0, 1 mM DTT, 24 and 48 h; Lane 12: 
standards, a is cholesterol, b is coprostanol, 
c is 4—cholesten—3—one, and d is an unknown 
contaminant 
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Figure 8. TLC of cultures of strain HL incubated 18 h 
in BC medium at various initial pH values. 
Lane 1: coprostanol standard; Lane 2: pH 8.0; 
Lane 3: pH 7.5; Lane 4; pH 7.2; Lane 5: pH 7.0; 
Lane 6: pH 6.8; Lane 7: pH 6.5; Lane 8: pH 6.0; 
Lane 9: pH 5.5. Spot a is unknown, b is 
cholesterol, and c is coprostanol 
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When strain HL was grown in BLEC medium (no 
cholesterol), growth was apparent because the medium assumed 
a grainy appearance. After transferring the bacterium up to 
10 times in BLEC medium, inoculation into BC medium resulted 
in rapid and efficient cholesterol reduction, indicating that 
strain HL was capable of growing in a cholesterol-free medium 
and that the cholesterol-reducing ability was maintained in 
the absence of substrate. When strain HL was inoculated into 
B medium (no cholesterol or lecithin), no growth (turbidity) 
was evident, and after several transfers, then inoculation 
into BC medium, no growth or cholesterol reduction resulted. 
The results of TLC assays for phospholipase activity are 
illustrated in Figure 9. When strain HL was grown in BLEC 
medium, lecithin was metabolized, as evidenced by the 
disappearance of lecithin and the appearance of free fatty 
acids. 
When a mixture of formate/fumarate was added to BC 
medium, there was no obvious stimulation of coprostanol 
production (data not shown). Other substrates were also 
examined (Figure 2). After 2 d of incubation, the amount of 
coprostanol produced by strain HL was approximately equal in 
BC medium with and without a variety of fermentable 
substrates. However, coprostanol production was slightly 
stimulated by the addition of sodium pyruvate to BC medium 
(lane 4, Figure 2) and, as shown in Figure 7 (lane 8), after 
24 h coprostanol production was stimulated by the addition of 
sodium acetate to the growth medium. DTT was inhibitory 
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phospholipid FFA 
Figure 9. TLC for phospholipids and free fatty acids (FFA) 
of strain HL incubated 1 d in BLEC medium, 
phopholipids; Lane 1, culture; Lane 2, ^ . 
uninoculated broth; Lane 3, 40% pure phosphatidyl 
choline; Lane 4, 99% pure phosphatidyl choline 
from soybean; Lane 5, 99% pure phosphatidyl 
choline from egg yolk. FFA: Lane 1, culture; 
Lane 2, uninoculated broth; Lane 3, oleic acid 
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(compare lanes 6 and 10, Figure 7), although some coprostanol 
was produced after 48 h. As observed with mixed cultures of 
CRB (Part I), CaClg greatly stimulated coprostanol formation 
(data not shown). When MgClg was substituted, coprostanol 
production was not stimulated (data not shown). No 
cholesterol was reduced when cultures were incubated at room 
temperature or at 55°C (Figure 10). The most efficient 
conversion of cholesterol to coprostanol by strain HL in EC 
medium occurred at 37°C (Figure 10). 
When cholesterol was added as an ethanolic solution to 
BP medium in the absence of phospholipid, no cholesterol 
reduction occurred (Figure 11). The greatest amount of 
coprostanol was produced when cholesterol was added to BP 
medium in combination with a 40% pure preparation of 
phosphatidyl choline (Sigma type IV-S soybean lecithin). 
Cholesterol was also converted to coprostanol when a 
preparation of nearly pure phosphatidyl choline (97% 
phosphatidyl choline) was added with cholesterol. No 
coprostanol was produced in BP medium by strain HL when 
cholesterol was added with phosphatidyl inositol, or 
phosphatidyl glycerol. When 4-cholesten-3-one or cholesterol 
were added with a 40% pure preparation of phosphatidyl 
choline to BP medium, 100% of the sterols (as detected 
visually) were converted to coprostanol (Figure 12). When 
radiolabeled coprostanone was added to BC broth inoculated 
with strain HL, approximately 50% of the coprostanone was 
converted to coprostanol in 3 d (Ren, D. 1991. M.S. thesis, 
107 
# # # Coprostanol 
Cholesterol 
Figure 10. TLC of culture extracts after incubation of 
strain HL for 4 d in BC medium at various 
temperatures. Lane 1: room temperature; 
Lane 2; 30°C; Lane 3: 37°C; Lane 4: 45°C; 
Lane 5: 55°C; Lane 6: standards 
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Figure 11. TLC of strain HL incubated for 14 d in 
cholesterol-containing BP medium with and 
without the addition of various phospholipids. 
Lane 1: no phospholipid; Lane 2: 97% pure 
phosphatidyl choline; Lane 3: 40% pure 
phosphatidyl choline: Lane 4: phosphatidyl 
inositol; Lane 5: phosphatidyl glycerol; Lane 
6 : standards 
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Coprostanol 
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Figure 12. TLC of cultures of strain HL after 1 week 
incubation in B medium plus 2 mg per ml sterol. 
Lane 1: 4-cholesten-3-one. Lane 2; cholesterol. 
Lane 3: cholesterol, uninoculated. Lane 4: 
4-cholesten-3-one, uninoculated. Lane 5: 
standards 
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Iowa State University, Ames, lA). 
Strain HL did not grow in media without cholesterol and 
lecithin, even when supplemented with glycerol, lactose, 
pyruvate, oleate, hemin, or vitamin (data not shown). 
Growth was also not observed when strain HL was inoculated 
into a basal medium containing the water-soluble sterol 
5-androstene-3B-ol-17B-carboxylic acid (data not shown). 
However, strain HL did grow in XLP medium. This medium 
contained a bovine lipoprotein fraction as a soluble source 
of cholesterol, and was supplemented with lactose and 
pyruvate. After 5 successive transfers in XLP medium, growth 
and coprostanol production occurred when strain HL was 
transferred into BC medium. Growth in XLP broth was 
evidenced as a uniform turbidity, with no grainy appearance 
as was noted for growth of strain HL in BLEC medium. After 3 
d of incubation in XLP or BC media, dilutions of strain HL 
were plated to MLA plates and incubated in a GasPak jar. 
Plate counts indicated that a cell density of about 3 X 10^ 
was achieved in XLP medium compared to about 3 x 10® in BC 
broth. 
Strain HL grew and reduced cholesterol in nitrate 
medium, but was negative for nitrate reduction. Indole 
production was negative in BC medium, and starch and gelatin 
were not hydrolyzed. Esculin was hydrolyzed. Much acid was 
produced by the fermentation of amygdalin, lactose, and 
salicin. Strain HL also weakly fermented arabinose, 
cellobiose, fructose, glucose, mannose, and melibiose. The 
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pH of the basal medium with no added carbohydrates also 
decreased from an average value of 6.95 to an average value 
of 6.18. The production of Hg and CO^ by strain HL in 
various media is listed in Table 1. The percentages of 
headspace gas volumes occupied by and CO^ ranged from 
4.5-7.2 and 0.9-1.8, respectively. The amounts of 
short-chain fatty acids produced by strain HL when grown in 
various media are listed in Table 2. Amounts of acetic acid 
produced ranged from 0.105 to 1.079 meq/100 ml. Between 0 
and 0.196 meq/100 ml of formic acid was produced, and amounts 
of succinic acid ranged from 0.027 to 0.392 meq/100 ml. No 
alcohols were produced. 
When strain HL was tested using the An-IDENT system, a 
positive reaction was evident for B-glucosidase, and for the 
hydrolysis of indoxyl-acetate. All of the other tests were 
negative. 
Strain HL survived exposure to air for up to 48 h. No 
growth was evident on inoculated MLA plates incubated in a 
candle jar, in an evacuated vacuum jar, or in air. 
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Table 1. Average percentage of the headspace gas volume 
occupied by H, or C0_ of various media 
after inoculation with strain HL and incubation 
for 4 d at 37°C 
Media Percentage of headspace gas 
H, CO, 
BC 4.5 ± 0.1^ 
o
 
H
 ± 0.0 
BCG^ 7.1 ± 1.0 1.2 ± 0.1 
BCP° 6.6 ± 1.0 0.9 ± o
 
to
 
BCLpd 7.2 ± 1.0 1.8 ± 0.2 
^ Mean of 2 observations ± standard deviation. 
^ BC medium plus 1.0% glucose. 
° BC medium plus 0.5% pyruvate. 
^ BC medium plus 0.5% lactose and 0.5% sodium pyruvate. 
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Table 2. Average amounts of 
produced by strain 
incubation for 4 d 
metabolic end products 
HL in various media after 
at 37°C 
Media® End products 
Acetic acid Formic acid Succinic acid 
BC 0. 105 ± 0. 003b 0 0 .027 ± 0 .002 
BCG 0. 196 + 0. 005 0. 196 ± 0. 030 0 .106 ± 0 .004 
BCP 0. 859 ± 0. 001 0. 135 ± 0. 014 0 .118 ± 0 .003 
BCLP 1. 079 ± 0. Oil ND° 0 .392 ± 0 .007 
SGM 0. 395 ± 0. 005 ND° 0 .070 ± 0 .008 
® Media abbreviations are defined in Table 1, and in 
Materials and Methods (Part II). 
^ Mean of 2 observations ± standard deviation. Units are 
meq/100 ml. 
° The areas of these peaks were not calculated by the 
gas chromatograph integrator; however, a small formate 
peak could be observed visually on inoculated media 
samples. No formate peak was observed on uninoculated 
media samples. 
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Discussion 
The values for the amount of cholesterol reduced to 
coprostanol after 2 d of incubation were different when 
values calculated from the radiolabeled assay were compared 
to values estimated from the visual examination of TLC 
plates. These discrepancies resulted for several reasons. 
First, quantitative values could not be determined from the 
visualization technique, although rough estimates could be 
made. Also, the growth of strain HL may have been slower in 
the medium containing the radiolabeled substrate than in the 
normal growth medium, because of the unavoidable introduction 
of some oxygen when the radiolabeled substrate was added to 
the medium, and the presence of a small amount of ethanol. 
Finally, both assays are subject to substantial variation, 
although replicates were run to reduce these errors. 
The observation that resting cells of strain HL grown in 
BC.l medium or SGM had higher cholesterol reductase activity 
than cells grown in BC medium may be explained by the 
competition between the nonradiolabeled and radiolabeled 
cholesterol. 
When strain HL was grown in media that contained 
cholesterol and lecithin, or lecithin in the absence of 
cholesterol, a very obvious coagulation of the medium 
occurred (see Figure 1, Part I). The mechanism that results 
in coagulation is not known. It may have been caused by the 
production of free fatty acids that resulted from the 
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hydrolysis of phosphatidyl choline. Whatever the reason for 
the coagulation, it was a quick and reliable indicator of 
coprostanol production because cholesterol reductase 
activities were always high in media that had coagulated and 
low in media that had not coagulated. There also appeared to 
be a relationship between coagulation and cell numbers. 
Mott and Brinkley (1979) observed that most of the 
previously isolated strains of CRB required 
plasmenylethanolamine to reduce cholesterol to coprostanol. 
They determined that the plasmalogen was metabolized, as 
evidenced by its disappearance from the growth medium. The 
end products of the metabolism of plasmalogen were not 
reported. It was also observed that Eubacterium ATCC 21408 
had sphingomyelinase activity. However, none of the 
metabolites of sphingomyelin supported growth of the 
bacterium (Mott and Brinkley, 1979). The ways by which 
phospholipase or sphingomyelinase activity are related to 
cholesterol-reducing activity are not known. One possibility 
is that these compounds or their metabolites alter the 
bacterial membrane in some way to make cholesterol more 
accessible to cholesterol reductase. They also may affect 
the type of micelle structure that the cholesterol substrate 
is imbedded in to increase the availability of cholesterol. 
When glycerol or free fatty acids were added with 
cholesterol to a basal medium, strain HL did not grow or 
reduce cholesterol. This suggests that the actual enzymatic 
hydrolysis of phosphatidyl choline was necessary for strain 
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HL to reduce cholesterol. The addition of CaClg had a 
stimulatory effect on coprostanol formation by strain HL. It 
has been reported that the phospholipid substrate must have a 
net positive charge for enzymatic action by phospholipase C 
2+ (Ottolenghi, 1967). The positive charge is supplied by Ca , 
an activator of phospholipase C. Perhaps the hydrolysis of 
phosphatidyl choline provides a cofactor, or acts directly in 
coprostanol formation. These questions can more easily be 
answered when a cell-free cholesterol reductase preparation 
is available. 
Brinkley and coworkers (1982) reported that several 
strains of CRB could grow on supplemented brain heart 
infusion agar plates incubated in an anaerobic chamber. When 
the strains were repeatedly subcultured, they maintained 
their ability to reduce cholesterol. However, when I plated 
strain HL on the same medium used by Brinkley et al. (1982) 
and incubated the plates in a GasPak jar, no colonies were 
observed. However, MLA medium prepared without cholesterol 
(but with lecithin) did support the growth of strain HL, and 
the colonies were similar in appearance to colonies on MLA 
medium with cholesterol (described in Part I, illustrated in 
Figure 2, Part I). It is possible that the requirement for 
lecithin for colony formation is unique to strain HL. 
Strain HL grew and retained its cholesterol-reducing 
ability after ten transfers in BLEC (cholesterol-free) 
medium. It is possible that a very minute amount of a 
phytosterol with a structure similar to cholesterol was 
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present in the crude soybean lecithin that was used in BLEC 
medium. However, no sterols with the retention value of 
cholesterol were detected by TLC assay of BLEC medium. The 
TLC assay used was sensitive enough to detect approximately 
20 ng sterol per ml of culture medium. The amount of 
cholesterol or phytosterol that may have been present in the 
crude lecithin was well below the 1 mg per ml that was 
required for the maintainence of Eubacterium ATCC 21408 
(Eyssen et al., 1973). 
Some question remains as to the exact mechanism of 
biohydrogenation of cholesterol to coprostanol by strain HL 
(Figure 13). If coprostanol is produced via a multiple-step 
pathway, two of the intermediates are probably 
4-cholesten-3-one and coprostanone. Strain HL converted both 
of these intermediates into coprostanol. However, no 
evidence of these intermediates was observed after incubation 
of strain HL in cholesterol-containing media, either by the 
standard TLC assay or by the more sensitive radiolabeled 
cholesterol TLC assay. Information obtained by using a 
dual-labeled cholesterol substrate suggested that coprostanol 
formation by strain HL involved the transfer of a hydrogen at 
C-4 to C-6. The most likely explanation for these 
observations was that there was an intramolecular hydrogen 
transfer with the transient formation of a double bond at C-4 
(Ren, D. 1991, M.S. thesis, Iowa State University, Ames, 
lA). Apparently, coprostanol is formed by strain HL with the 
intermediate formation of 4-cholesten-3-one and possibly 
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AH, 
CHOLESTEROL CH0LEST-5-EN-3-0NE 
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\ 
I 
?8«17 
AH, 
H 
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CHOLEST-4-EN-3-ONE 
AH2. 
H 
COPROSTAN-3-ONE 
Figure 13. Possible reaction sequences for cholesterol 
reduction to coprostanol 
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coprostanone, but no intermediates accumulate. It is 
possible that cholesterol reductase from strain HL exists as 
a complex of physically linked enzymes, or that cholesterol 
reductase is a single enzyme capable of carrying out several 
different reactions. 
Stain HL closely resembles other members of the genus 
Eubacterium. Strain HL appears to be quite similar to 
strains 103 and 104 that were isolated by Brinkley et al. 
(1982) and were classified as Eubacterium sp. These strains 
had carbohydrate fermentation patterns similar to strain HL, 
produced B-glucosidase, hydrolyzed esculin, and metabolized 
pyruvate. Strains 103, 104, and HL all produced acetic acid 
and succinic acid. 
Strains 103 and 104 grew on supplemented BHI agar plates 
with no cholesterol or lecithin, while strain HL did not grow 
in the absence of lecithin. Strains 103 and 104 reduced 
cholesterol to coprostanol in the absence of plasmalogen but 
were only tested in media that contained lecithin and 
cholesterol. The requirement of lecithin for cholesterol 
reduction and the presence of phospholipase activity were not 
tested in strains 103 and 104. Strains 103 and 104 produced 
from 1 to 11% COg in the headspace of brain medium and 9 to 
20% COg in brain medium supplemented with pyruvate; no H^ was 
produced (Brinkley et al., 1982). This was in contrast to 
strain HL, which produced approximately 1% CO^ (a value that 
did not increase with pyruvate addition) and up to 
approximately 7% Hg. Strain HL also varied from strains 103 
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and 104 in its production of formate, although the methods 
used by Brinkley and coworkers may not have detected formate 
production (Brinkley and Mott, 1978). 
Another possible difference between strains 103 and 104 
and strain HL is the aerotolerance of the strains. Strain HL 
required anaerobic conditions to grow, but survived long 
exposures to atmospheric oxygen. Unfortunately, data on the 
aerotolerance of strains 103 and 104 were not published, and 
the strains were not available for comparison. Strain HL was 
negative for catalase activity, and the way that this 
bacterium is protected from oxygen merits further study. 
When strain HL was grown in a medium containing 2 mg per 
ml cholesterol (BCLP), or 0.2 mg per ml cholesterol (SGM), 
decreases in the amounts•of acetic and succinic acids were 
observed in the medium with less cholesterol. This 
difference was probably caused by a stimulation of the 
metabolism of strain HL by cholesterol, or by an increase in 
cell numbers in the presence of increased cholesterol 
concentrations. 
When sodium pyruvate was present in the growth medium, 
strain HL produced significantly more acetic acid than in 
media without pyruvate, while the amounts of formic acid and 
succinic acid remained approximately the same. Pyruvate was 
metabolized by strain HL. This was evidenced by its 
disappearance from the growth medium as determined by GC 
analysis (data not shown). When pyruvate was added to the 
growth medium of strain HL that was harvested and used as the 
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enzyme source for radiolabeled cholesterol reduction, 
activity was stimulated. Pyruvate also stimulated 
cholesterol reductase activity when it was added as a 
component of the reaction mixture. It is possible that 
pyruvate acts directly as a cofactor in cholesterol 
reduction. Other workers reported a similar observation; 
pyruvate acted as an electron donor for 
16-dehydroprogesterone reductase in cell extracts of 
Eubacterium sp. strain 144 (Watkins and Glass, 1991). More 
definitive data will become available on the 
interrelationships of pyruvate with cholesterol reductase 
when activity can be assayed in cell-free extracts of strain 
HL. 
The significance of cholesterol reduction by strain HL 
or other CRB to the physiology of the bacteria remains to be 
elucidated. Eyssen et al. (1973) speculated that cholesterol 
acted as a terminal electron acceptor in CRB, thereby 
supplying energy by means of electron transport. However, 
several strains do not require cholesterol for growth, 
suggesting that some CRB can use alternate electron 
acceptors, or generate energy by another mechanism (Brinkley 
et al., 1982). The spirochete Treponema hyodysenteriae 
required cholesterol for growth and reduced cholesterol to 
cholestanol (Stanton, 1987), Cholestanol was incorporated 
into the cellular lipids. The ability of several CRB to grow 
in the absence of cholesterol precludes its neccessity as a 
cellular membrane component, at least in certain strains. 
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GENERAL SUMMARY 
In Part I, several different media and methods were used 
to attempt to grow previously isolated strains of 
cholesterol-reducing bacteria (CRB) in clear media to 
facilitate the preliminary steps of cholesterol reductase 
isolation. It was concluded that the existing strains of CRB 
could not be used as sources of cholesterol reductase. The 
existing strains were too fastidious, and cholesterol 
reductase activities were low. Therefore, new media and 
methods were used to isolate bacteria with more desirable 
characteristics. 
Stable mixed cultures were obtained from a variety of 
samples. Most of these sample types had never before been 
studied as possible sources for obtaining CRB. Two strains 
of CRB were isolated, one from a hog sewage lagoon and 
another from standing water. 
In Part II, the hog sewage lagoon isolate, Eubacterium 
sp. strain HL, was characterized. This isolate has several 
characteristics that make it a better candidate for future 
uses in reducing the cholesterol content of foods when 
compared to previous isolates of CRB. These characteristics 
include the ability to grow without cholesterol or 
plasmalogen, aerotolerance, and the ability to form colonies 
on a solid medium incubated in GasPak jars. The metabolism 
of strain HL appears to be different from other Eubacterium 
spp. Perhaps the greater diversity of CRB now available will 
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eventually lead to a better understanding of the role that 
cholesterol reduction plays in the physiology of CRB and to 
industrial applications of these unique bacteria. 
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